See veebileht kasutab küpsiseid kasutaja sessiooni andmete hoidmiseks. Veebilehe kasutamisega nõustute ETISe kasutustingimustega. Loe rohkem
Olen nõus

Külli Kingo

https://www.etis.ee/CV/Külli_Kingo/est
7.04.1972
731 9706
kylli.kingo@ut.ee
H-3603-2012

Teenistuskäik

Töökohad ja ametid
01.02.2017–...   
Tartu Ülikool, Meditsiiniteaduste valdkond, kliinilise meditsiini instituut, dermatoloogia ja veneroloogia professor (1,00)
2012–...   
SA Tartu Ülikooli Kliinikum, tartu Ülikooli Kliinikumi Nahakliinik, kliiniku juhataja (0,50)
01.01.2010–...   
Tartu Ülikool, Kliinilise meditsiini doktorikooli projektijuht (1,00)
2001 – SA TÜK Nahahaiguste Kliinik, arst-õppejõud
01.02.2017–31.01.2021   
Tartu Ülikool, Meditsiiniteaduste valdkond, kliinilise meditsiini instituut, nahahaiguste kliiniku juhataja (1,00)
01.02.2017–31.12.2019   
Tartu Ülikool, Meditsiiniteaduste valdkond, teadusprodekaan (1,00)
01.01.2016–31.01.2017   
Tartu Ülikool, Meditsiiniteaduste valdkond, kliinilise meditsiini instituut, dermatoloogia ja veneroloogia professor (1,00)
01.01.2016–31.01.2017   
Tartu Ülikool, Meditsiiniteaduste valdkond, teadusprodekaan
01.01.2016–31.01.2017   
Tartu Ülikool, Meditsiiniteaduste valdkond, kliinilise meditsiini instituut, kliiniku juhataja
24.05.2015–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Arstiteaduskonna dekanaat, teadusprodekaan
01.02.2015–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, kliiniku juhataja
24.05.2012–23.05.2015   
Tartu Ülikool, Arstiteaduskond, Arstiteaduskonna dekanaat, teadusprodekaan
01.05.2012–31.12.2015   
Tartu Ülikool, Teadusprodekaan, Arstiteaduskond, Tartu Ülikool (1,00)
01.02.2012–31.12.2015   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia professor (1,00)
01.02.2012–31.01.2015   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, kliiniku juhataja
01.09.2010–31.01.2012   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, kliiniku juhataja
01.09.2008–31.01.2012   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia dotsent (0,50)
01.09.2008–31.08.2012   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia vanemteadur (0,50)
01.09.2007–31.08.2008   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia vanemteadur (1,00)
01.02.2007–31.08.2007   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia erakorraline vanemteadur (1,00)
2007–2008   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, Dermatoloogia ja veneroloogia õppetool, Vanemteadur (1,00)
01.09.2005–31.01.2007   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, dermatoloogia ja veneroloogia teadur (1,00)
01.04.2005–31.08.2005   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, spetsialist (1,00)
01.04.2004–31.03.2005   
Tartu Ülikool, Arstiteaduskond, Nahahaiguste kliinik, erakorraline teadur (1,00)
 
 
Haridustee
1978 – 1990 Tartu 10. Keskkool
1990 – 1996 Tartu Ülikool, arstiteaduskond (cum laude)
1997 – 2001 Tartu Ülikool, residentuur dermatoveneroloogia erialal
2001 – 2005 Tartu Ülikool, doktorantuur dermatoveneroloogia erialal
 
 
Teadusorganisatsiooniline ja -administratiivne tegevus
2012−...   
Euroopa Dermatoveneroloogia Akadeemia juhatuse liige
2011−...   
Eesti Naha- ja Suguhaiguste Arstide Seltsi juhatuse liige
2006−...   
Euroopa Dermatoveneroloogia Akadeemia liige
2003−...   
Sugulisel Teel Levivate Infektsioonide Eesti Ühingu liige
2003−...   
Ida-Euroopa Dermatoveneroloogide Seltsi liige
2001−...   
Balti Dermatoveneroloogide Seltsi liige

Kvalifikatsioon

Teaduskraadid
Külli Kingo, doktorikraad, 2005, (juh) Eero Vasar; Sulev Kõks; Helgi Silm, The interleukin-10 family cytokines gene polymorphisms in plaque psoriasis (Interleukiin-10 perekonna tsütokiniinide geenide polümorfismid naastulise psoriaasi puhul), Tartu Ülikool, Arstiteaduskond.
 
 
Teaduspreemiad ja tunnustused
2016, Külli Kingo, Külli Kingo, Riigi teaduspreemia arstiteaduses
2004, Külli Kingo, Üliõpilaste teadustööde riikliku konkursi I preemia
 
 
Teadustöö põhisuunad
ETIS KLASSIFIKAATOR: 3. Terviseuuringud; 3.7. Kliiniline meditsiin; TÄPSUSTUS: Teadustöö eesmärgiks on tuvastada krooniliste dermatooside (psoriaas ja vitiliigo) tekkel osalevate geenide/biomolekulide võrgustik, mille funktsioneerimisel tekkivad häired viivad nimetatud haiguste kujunemisele. Töö põhieesmärkideks on: 1. uurida klass II tsütokiinide (HCII) ja nende retseptorite (HCRII) geneetiliste polümorfismide seoseid psoriaasi ja vitiliigoga ning hinnata uuritavate markerite (nii mRNA kui ka proteiini) ekspressioonitasemete erinevusi nahas ja veres tervetel kontrollidel ja haigetel; 2. selgitada närvisüsteemi regulatoorset rolli krooniliste dermatooside tekkemehhanismis, hinnates neurotransmitterite, neuropeptiidide ja neurohormoonide ning nende retseptorite ekspressioonitasemete erinevusi nahas ja veres tervetel kontrollidel ja haigetel.
 
 
Lisainfo
Ph.D.
Tartu Ülikool, arstiteaduskond, 10.06.2005

Jooksvad projektid

Lõppenud projektid

Juhendamisel väitekirjad

Juhendatud väitekirjad

Publikatsioonid

1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index, Emerging Sources Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
 
Bodemer C, Kaszuba A, Kingo K, Tsianakas A, Morita A, Rivas E, Papanastasiou P, Keefe D, Patekar M, Charef P, Zhang L, Cafoncelli S, Papavassilis C. (2021). Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomised, controlled trial. Journal of the European Academy of Dermatology and Venereology. DOI: 10.1111/jdv.17002 [ilmumas].
 
Ilves, Liis; Ottas, Aigar; Kaldvee, Bret; Abram, Kristi; Soomets, Ursel; Zilmer, Mihkel; Reemann, Paula; Jaks, Viljar; Kingo, Külli (2021). The metabolomic analysis of skin biopsies from atopic dermatitis patients reveals hallmarks of inflammation, disrupted barrier function and oxidative stress. Acta Dermato-Venereologica, 101 (2). DOI: /doi.org/10.2340/00015555-3766.
 
Frey, Silke; Sticht, Heinrich; Wilsmann-Theis, Dagmar; Gerschütz, Anne; Wolf, Katharina; Löhr, Sabine; Haskamp, Stefan; Frey, Benjamin; Hahn, Madelaine; Ekici, Arif B.; Uebe, Steffen; Thiel, Christian; Reis, André; Burkhardt, Harald; Behrens, Frank; Köhm, Michaela; Rech, Jürgen; Schett, Georg; Assmann, Gunter; Kingo, Külli ... Hüffmeier, Ulrike (2020). Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis. Journal of Investigative Dermatology, 13. DOI: 10.1016/j.jid.2019.11.024.
 
Pohla, Liis; Ottas, Aigar; Kaldvee, Bret; Abram, Kristi; Soomets, Ursel; Zilmer, Mihkel; Reemann, Paula; Jaks, Viljar; Kingo, Külli (2020). Hyperproliferation is the main driver of metabolomic changes in psoriasis lesional skin. Scientific Reports, 10 (1), 3081−3081. DOI: 10.1038/s41598-020-59996-z.
 
Saare, Mario; Tserel, Liina; Haljasmägi, Liis; Taalberg, Egon; Peet, Nadežda; Eimre, Margus; Vetik, Rait; Kingo, Külli; Saks, Kai; Tamm, Riin; Milani, Lili; Kisand, Kai; Peterson, Pärt (2020). Monocytes present age-related changes in phospholipid concentration and decreased energy metabolism. Aging Cell, ARTN e13127. DOI: 10.1111/acel.13127.
 
Vaher, Helen; Kivihall, Anet; Runnel, Toomas; Raam, Liisi; Prans, Ele; Maslovskaja, Julia; Abram, Kristi; Kaldvee, Bret; Mrowietz, Ulrich; Weidinger, Stephan; Kingo, Külli; Rebane, Ana (2020). SERPINB2 and miR-146a/b are coordinately regulated and act in the suppression of psoriasis-associated inflammatory responses in keratinocytes. Experimental Dermatology, 29 (1), 51−60. DOI: 10.1111/exd.14049.
 
Augustin, M.; Dauden, E.; Mrowietz, U.; Konstantinou, M. P.; Gerdes, S.; Kingo, K.; Szepietowski, J. C.; Perrot, J. L.; Cuccia, A.; Rissler, M.; Gathmann, S.; Sieder, C.; Orsenigo, R.; Jagiello, P.; Bachhuber, T. (2020). Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results. Journal of the European Academy of Dermatology and Venereology. DOI: 10.1111/jdv.16632.
 
Benzian-Olsson N, Dand N, Chaloner C, Bata-Csorgo Z, Borroni R, Burden AD, Cooper HL, Cornelius V, Cro S, Dasandi T, Griffiths CEM, Kingo K, Koks S, Lachmann H, McAteer H, Meynell F, Mrowietz U, Parslew R, Patel P, Pink AE, Reynolds NJ, Tanew A, Torz K, Trattner H, Wahie S, Warren RB, Wright A, Barker JN, Navarini AA, Smith CH, Capon F; ERASPEN consortium and the APRICOT and PLUM study team. (2020). Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis. JAMA Dermatology. DOI: 10.1001/jamadermatol.2020.3275.
 
Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F. (2019). Clinical and genetic differences between pustular psoriasis subtypes. The Journal of Allergy and Clinical Immunology.10.1016/j.jaci.2018.06.038.
 
Traks, Tanel; Keermann, Maris; Prans, Ele; Karelson, Maire; Loite, Ulvi; Kõks, Gea; Silm, Helgi; Kõks, Sulev; Kingo, Külli (2019). Polymorphisms in IL36G gene are associated with plaque psoriasis. BMC Medical Genetics, 20 (1), 10−10.10.1186/s12881-018-0742-2.
 
Lille Kurvits , Ene Reimann, Liis Kadastik-Eerme, Laura Truu, Külli Kingo, Triin Erm, Sulev Kõks, Pille Taba, Anu Planken (2019). Serum amyloid alpha is downregulated in peripheral tissues of Parkinson’s disease patients. Frontiers in Neuroscience, 13 (13). DOI: 10.3389/fnins.2019.00013.
 
Traks, Tanel; Keermann, Maris; Karelson, Maire; Rätsep, Ranno; Reimann, Ene; Silm, Helgi; Vasar, Eero; Kõks, Sulev; Kingo, Külli (2019). Polymorphisms in Corticotrophin-releasing Hormone-proopiomelanocortin (CRH-POMC) System Genes are Associated with Plaque Psoriasis. Acta Dermato Venereologica. DOI: 10.2340/00015555-3137.
 
van Vugt LJ, van den Reek JMPA, Meulewaeter E, Hakobjan M, Heddes N, Traks T, Kingo K, Galluzzo M, Talamonti M, Lambert J, Coenen MJH, de Jong EMGJ. (2019). Response to IL17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL17A gene: results from a multicentre study of four European psoriasis cohorts. Journal of the European Academy of Dermatology and Venereology.10.1111/jdv.15787.
 
Reimann, Ene; Abram, Kristi; Koks, Sulev; Kingo, Kulli; Fazeli, Alireza (2019). Identification of an optimal method for extracting RNA from human skin biopsy, using domestic pig as a model system. Scientific Reports, 9, ARTN 20111. DOI: 10.1038/s41598-019-56579-5.
 
Thaci, Diamant; Puig, Lluis; Reich, Kristian; Tsai, Tsen-Fang; Tyring, Stephen; Kingo, Kulli; Ziv, Michael; Pinter, Andreas; Vender, Ronald; Lacombe, Aude; Xia, Summer; Bhosekar, Vaishali; Gilloteau, Isabelle; Guana, Adriana; Blauvelt, Andrew (2019). Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderateto-severe psoriasis through 2 years of treatment: Results from the CLEAR study. Journal of the American Academy of Dermatology, 81 (6), 1405−1409. DOI: 10.1016/j.jaad.2019.04.045.
 
Vaher, Helen; Runnel, Toomas; Urgard, Egon; Aab, Alar; Carreras Badosa, Gemma; Maslovskaja, Julia; Abram, Kristi; Raam, Liisi; Kaldvee, Bret; Annilo, Tarmo; Tkaczyk, Eric R; Maimets, Toivo; Akdis, Cezmi A; Kingo, Külli; Rebane, Ana (2019). miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation. Allergy, 74 (11), 2146−2156. DOI: 10.1111/all.13849.
 
Reimann, Ene; Lättekivi, Freddy; Keermann, Maris; Abram, Kristi; Kõks, Sulev; Kingo, Külli; Fazeli, Alireza (2019). Multicomponent Biomarker Approach Improves the Accuracy of Diagnostic Biomarkers for Psoriasis Vulgaris. Acta Dermato Venereologica, 99 (13), 1258−1265. DOI: 10.2340/00015555-3337.
 
Lattekivi, Freddy; Kõks, Sulev; Keermann, Maris; Reimann, Ene; Prans, Ele; Abram, Kristi; Silm, Helgi; Kõks, Gea; Kingo, Külli (2018). Transcriptional landscape of human endogenous retroviruses (HERVs) and other repetitive elements in psoriatic skin. Scientific Reports, 8, ARTN 4358. DOI: 10.1038/s41598-018-22734-7.
 
Mössner, R; Wilsmann-Theis, D; Oji, V; Gkogkolou, P; Löhr, S; Schulz, P; Körber, A; Prinz, J C; Renner, R; Schäkel, K; Vogelsang, L; Peters, K-P; Philipp, S; Reich, K; Ständer, H; Jacobi, A; Weyergraf, A; Kingo, K; Kõks, S; Gerdes, S ... Hüffmeier, U (2018). The genetic basis for most patients with pustular skin disease remains elusive. British Journal of Dermatology, 1−9.10.1111/bjd.15867.
 
Carreras-Badosa, Gemma; Runnel, Toomas; Plaas, Mario; Kärner, Jaanika; Rückert, Beate; Lättekivi, Freddy; Kõks, Sulev; Akdis, Cezmi A; Kingo, Külli; Rebane, Ana (2018). microRNA-146a is linked to the production of IgE in mice but not in atopic dermatitis patients. Allergy, 73 (12), 2400−2403. DOI: 10.1111/all.13579.
 
Raam, Liisi; Kaleviste, Epp; Sunina, Marina; Vaher, Helen; Saare, Mario; Prans, Ele; Pihlap, Maire; Abram, Kristi; Karelson, Maire; Peterson, Part; Rebane, Ana; Kisand, Kai; Kingo, Kulli (2018). Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis. Frontiers in Immunology, 9, ARTN 2707. DOI: 10.3389/fimmu.2018.02707.
 
Kärner, J; Wawrzyniak, M; Tankov, S; Runnel, T; Aints, A; Kisand, K; Altraja, A; Kingo, K; Akdis, C A; Akdis, M; Rebane, A (2017). Increased microRNA-323-3p in IL-22/IL-17-producing T cells and asthma: a role in the regulation of the TGF-β pathway and IL-22 production. Allergy, 72 (1), 55−65.10.1111/all.12907.
 
Kõks, Sulev; Keermann, Maris; Reimann, Ene; Prans, Ele; Abram, Kristi; Silm, Helgi; Kõks, Gea; Kingo, Kulli (2017). Psoriasis-Specific RNA Isoforms Identified by RNA-Seq Analysis of 173,446 Transcripts. Frontiers in Medicine, 3, 46. DOI: 10.3389/fmed.2016.00046.
 
Ottas, Aigar; Fishman, Dmytro; Okas, Tiia-Linda; Kingo, Külli; Soomets, Ursel; (2017).

The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease

. Archives of Dermatological Research, 309 (7), 519−528.10.1007/s00403-017-1760-1.
 
Planken, A.; Kurvits, L.; Reimann, E.; Kadastik-Eerme, L.; Kingo, K.; Kõks, S.; Taba, P.; (2017). Looking beyond the brain to improve the pathogenic understanding of Parkinson's disease: Implications of whole transcriptome profiling of Patients' skin. BMC Neurology, 17 (6), 6−6. DOI: 10.1186/s12883-016-0784-z.
 
Navarini, A A; Burden, A D; Capon, F; Mrowietz, U; Puig, L; Köks, S; Kingo, K; Smith, C; Barker, J N; , (2017). European consensus statement on phenotypes of pustular psoriasis. Journal of the European Academy of Dermatology and Venereology, 31 (11), 1792−1799.10.1111/jdv.14386.
 
Tsoi, Lam C.; Stuart, Philip E.; Tian, Chao; Gudjonsson, Johann E.; Das, Sayantan; Zawistowski, Matthew; Ellinghaus, Eva; Barker, Jonathan N.; Chandran, Vinod; Dand, Nick; Duffin, Kristina Callis; Enerback, Charlotta; Esko, Tonu; Franke, Andre; Gladman, Dafna D.; Hoffmann, Per; Kingo, Kulli; Koks, Sulev; Krueger, Gerald G.; Lim, Henry W. ... Elder, James T. (2017). Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nature Communications, 8, ARTN 15382. DOI: 10.1038/ncomms15382.
 
Griffiths CEM, Thaci D, Gerdes S, Arenberger P, Pulka G, Kingo K, Weglowska J, EGALITY study group, Hattebuhr N, Poetzl J, Woehling H, Wuerth G, Afonso M. (2017). The EGALITY study: a confirmatory, randomized, double-blind stydy comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis. British Journal of Dermatology, 176 (4), 928−938.10.1111/bjd.15152.
 
Blauvelt, A, Reich K, Tsai TF, Tyring S, Vanaclocha F, Kingo K, Ziv M, Pinter A, Vender R, Hugot S, You R, Milutinovic M, Thaçi D. (2017). Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 76 (1), 60−69.10.1016/j.jaad.2016.08.008.
 
Khobzey K, Liskova I, Szegedi A, Pavlovsky L, Lunder T, Kingo K, Miljković J, Péč J, Bohinc M, Hojnik M. (2017). Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice. Acta Dermatovenerologica Alpina, Pannonica et Adriatica, 26, 1, 11−14.
 
Galimova, E.; Khusnutdinova, E.; Rätsep, R.; Traks, T.; Kingo, K.; Escott-Price, V.; Kõks, S. (2017). Interleukin-10 family cytokines pathway: genetic variants and psoriasis. British Journal of Dermatology, 1−14.10.1111/bjd.15363.
 
Šahmatova, Liisi; Sügis, Elena; Šunina, Marina; Hermann, Helen; Prans, Ele; Pihlap, Maire; Abram, Kristi; Rebane, Ana; Peterson, Hedi; Peterson, Pärt; Kingo, Külli; Kisand, Kai (2017). Signs of innate immune activation and premature immunosenescence in psoriasis patients. Scientific Reports, 7 (1), 7553−7553. DOI: 10.1038/s41598-017-07975-2.
 
Ottas, Aigar; Fishman, Dmytro; Okas, Tiia-Linda; Pussa, Tonu; Toomik, Peeter; Martson, Aare; Kingo, Kulli; Soomets, Ursel (2017).

Blood serum metabolome of atopic dermatitis: Altered energy cycle and the markers of systemic inflammation

. PLoS ONE, 12 (11), ARTN e0188580. DOI: 10.1371/journal.pone.0188580.
 
Traks, Tanel; Karelson, Maire; Reimann, Ene; Rätsep, Ranno; Silm, Helgi; Vasar, Eero; Kõks, Sulev; Kingo, Külli (2016). Association analysis of class II cytokine and receptor genes in vitiligo patients. Human Immunology, 77 (5), 375−381.10.1016/j.humimm.2015.09.050.
 
Šahmatova, Liisi; Tankov, Stoyan; Prans, Ele; Aab, Alar; Hermann, Helen; Reemann, Paula; Pihlap, Maire; Karelson, Maire; Abram, Kristi; Kisand, Kai; Kingo, Külli; Rebane, Ana (2016). MicroRNA-155 is Dysregulated in the Skin of Patients with Vitiligo and Inhibits Melanogenesis-associated Genes in Melanocytes and Keratinocytes. Acta Dermato Venereologica, 96, 6, 742−747. DOI: 10.2340/00015555-2394.
 
Urgard, Egon; Lorents, Annely; Klaas, Mariliis; Padari, Kärt; Viil, Janeli; Runnel, Toomas; Langel, Kent; Kingo, Külli; Tkaczyk, Eric; Langel, Ülo; Maimets, Toivo; Jaks, Viljar; Pooga, Margus; Rebane, Ana (2016). Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis. Journal of Controlled Release, 235, 195−2014. DOI: 10.1016/j.jconrel.2016.06.006.
 
Jin, Ying; Andersen, Genevieve; Yorgov, Daniel; Ferrara, Tracey M.; Ben, Songtao; Brownson, Kelly M.; Holland, Paulene J.; Birlea, Stanca A.; Siebert, Janet; Hartmann, Anke; Lienert, Anne; van Geel, Nanja; Lambert, Jo; Luiten, Rosalie M.; Wolkerstorfer, Albert; van der Veen, J. P. Wietze; Bennett, Dorothy C.; Taieb, Alain; Ezzedine, Khaled; Kemp, E. Helen ... Spritz, Richard A. (2016). Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nature Genetics, 48 (11), 1418−1424. DOI: 10.1038/ng.3680.
 
Mägi, A; Unt, E; Prans, E; Raus, L;Eha, J; Veraksitš, A; Kingo, K; Kõks, S. (2016). The association analysis between ACE and ACTN3 genes polymorphisms and endurance capacity in young cross-country skiers: longitudinal study. Journal of Sports Science and Medicine, 15 (2), 287−294.
 
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. (2016). Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. New England Journal of Medicine, 375 (24), 2335−2348.10.1056/NEJMoa1610020.
 
Blauvelt A, Prinz JC, Gottlieb AB, Kingo K, et al. (2015). Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). British Journal of Dermatology, 172 (2), 484−493.10.1111/bjd.13348.
 
Mössner R, Frambach Y, Wilsmann-Theis D, Kingo K, et al (2015). Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients. Journal of Investigative Dermatology, 135 (10), 2538−2541.10.1038/jid.2015.186.
 
Thaçi D, Blauvelt A, Reich K, Tsai TF, Vanaclocha F, Kingo K, et al (2015). Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 73 (3), 400−409.10.1016/j.jaad.2015.05.013.
 
Traks T, Keermann M, Karelson M, Rätsep R, Reimann E, Silm H, Vasar E, Kõks S, Kingo K. (2015). Polymorphisms in Toll-like receptor genes are associated with vitiligo. Frontiers in Genetics, 6, x−x. DOI: 10.3389/fgene.2015.00278.
 
Keermann, Maris; Kõks, Sulev; Reimann, Ene; Abram, Kristi; Erm, Triin; Silm, Helgi; Kingo, Külli (2015). Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin. Journal of Dermatological Science, 80 (2), 150−152. DOI: 10.1016/j.jdermsci.2015.08.002.
 
Tsoi, L. C.; Spain, S. L.; Ellinghaus, E.; Stuart, P. E.; Capon, F.; Knight, J.; Tejasvi, T.; Kang, H. M.; Allen, M. H.; Lambert, S.; Stoll, S. W.; Weidinger, S.; Gudjonsson, J. E.; Kõks, S.; Kingo, K.; Esko, T.; Das, S.; Metspalu, A.; Weichenthal, M.; Enerback, C. ... Elder, J. T. (2015). Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nature Communications, 6 (7001), 1−8. DOI: 10.1038/ncomms8001.
 
Pärna, E.; Aluoja, A.; Kingo, K. (2015). Quality of Life and Emotional State in Chronic Skin Disease. Acta Dermato-Venereologica, 95 (3), 312−316.10.2340/00015555-1920.
 
Stuart, P. E.; Nair, R. P.; Tsoi, L. C.; Tejasvi, T.; Das, S.; Kang, H. M.; Ellinghaus, E.; Chandran, V.; Callis-Duffin, K.; Ike, R.; Li, Y. M.; Wen, X. Q.; Enerback, C.; Gudjonsson, J. E.; Kõks, S.; Kingo, K.; Esko, T.; Mrowietz, U.; Reis, A.; Wichmann, H. E. ... Elder, J. T. (2015). Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. The American Journal of Human Genetics, 97 (6), 816−836.10.1016/j.ajhg.2015.10.019.
 
Mössner, R.; Frambach, Y.; Wilsmann-Theis, D.; Löhr, S.; Jacobi, A.; Weyergraf, A.; Müller, M.; Philipp, S.; Renner, R.; Traupe, H.; Burkhardt, H.; Kingo, K.; Kõks, S.; Uebe, S.; Sticherling, M.; Sticht, H.; Oji, V.; Hüffmeier U. (2015). Palmoplantar pustular psoriasis is associated with missense variants in CARD14, but not with loss-of-function mutations in IL36RN in European patients. Journal of Investigative Dermatology, 135, 10, 2538−2541.
 
Keermann, M.; Kõks, S.; Reimann, E.; Prans, E.; Abram, K.; Kingo, K. (2015). Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN. BMC Genomics, 16, 322−333. DOI: 10.1186/s12864-015-1508-2.
 
Langley RG, Elewski BE, Lebwohl M, Reich K, ERASURE Study Group, FIXTURE Study Group. (2014). Secukinumab in plaque psoriasis--results of two phase 3 trials. New England Journal of Medicine, 371 (4), 326−338.10.1056/NEJMoa1314258.
 
Reemann, P.; Reimann, E.; Ilmjärv, S.; Porosaar, O.; Silm, H.; Jaks, V.; Vasar, E.; Kingo, K.; Kõks, S. (2014). Melanocytes in the skin - comparative whole transcriptome analysis of main skin cell types. PLoS ONE, 9 (12), e115717. DOI: 10.1371/journal.pone.0115717.
 
Siimon, Kaido; Reemann, Paula; Poder, Annika; Pook, Martin; Kangur, Triin; Kingo, Kulli; Jaks, Viljar; Maeorg, Uno; Jaervekuelg, Martin (2014). Effect of glucose content on thermally cross-linked fibrous gelatin scaffolds for tissue engineering. Materials Science and Engineering C, 42, 538−545. DOI: 10.1016/j.msec.2014.05.075.
 
Reemann, Paula; Reimann, Ene; Suutre, Siim; Paavo, Maarjaliis; Loite, Ulvi; Porosaar, Orm; Abram, Kristi; Silm, Helgi; Vasar, Eero; Koks, Sulev; Kingo, Kuelli (2014). Expression of Class II Cytokine Genes in Children's Skin. Acta Dermato-Venereologica, 94 (4), 386−392. DOI: 10.2340/00015555-1717.
 
Orro, Kadri; Smirnova, Olga; Arshavskaja, Jelena; Salk, Kristiina; Meikas, Anne; Pihelgas, Susan; Rumvolt, Reet; Kingo, Külli; Kazarjan, Aram; Neuman, Toomas; Spee, Pieter (2014). Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface. Biomarker Research, 2 (20), #20.10.1186/2050-7771-2-20.
 
Rebane, Ana; Runnel, Toomas; Aab, Alar; Maslovskaja, Julia; Rueckert, Beate; Zimmermann, Maya; Plaas, Mario; Käner, Jaanika; Treis, Angela; Pihlap, Maire; Haljasorg, Uku; Hermann, Helen; Nagy, Nikoletta; Kemeny, Lajos; Erm, Triin; Kingo, Külli; Li, Mei; Boldin, Mark P.; Akdis, Cezmi A. (2014). MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. Journal of Allergy and Clinical Immunology, 134 (4), 836−859. DOI: 10.1016/j.jaci.2014.05.022.
 
Karelson, M.; Silm, H.; Kingo, K. (2013). Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls. Acta Dermato-Venereologica, 93, 446−450.
 
Reemann, Paula; Kangur, Triin; Pook, Martin; Paalo, Madis; Nurmis, Liis; Kink, Ilmar; Porosaar, Orm; Kingo, Külli; Vasar, Eero; Kõks, Sulev; Jaks, Viljar; Järvekülg, Martin (2013). Fibroblast growth on micro- and nanopatterned surfaces prepared by a novel sol-gel phase separation method. Journal of Materials Science Materials in Medicine, 24 (3), 783−792. DOI: 10.1007/s10856-012-4829-6.
 
Loite, U; Kingo, K; Reimann, E; Reemann, P; Vasar, E; Silm, H; Kõks, S. (2013). Gene Expression Analysis of the Corticotrophin-releasing Hormone-proopiomelanocortin System in Psoriasis Skin Biopsies. Acta Dermato-Venereologica, 93 (4), 400−405. DOI: 10.2340/00015555-1524.
 
Prans, Ele; Kingo, Külli; Traks, Tanel; Silm, Helgi; Vasar, Eero; Kõks, Sulev (2013). Copy number variations in IL22 gene are associated with psoriasis vulgaris. Human Immunology, 74 (6), 792−795.10.1016/j.humimm.2013.01.006.
 
Reimann, E.; Kingo, K.; Karelson, M.; Reemann, P.; Loite, U.; Sulakatko, H.; Keermann, M.; Raud, K.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2012). The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells. Human Immunology, 73 (4), 393−398. DOI: 10.1016/j.humimm.2012.01.011.
 
Ellinghaus, E.; Stuart, PE.; Ellinghaus, D.; Nair, RP.; Debrus, S.; Raelson, JV.; Belouchi, M.; Tejasvi, T.; Li, Y.; Tsoi, LC.; Onken, AT.; Esko, T.; Metspalu, A.; Rahman, P.; Gladman, DD.; Bowcock, AM.; Helms, C.; Krueger, GG.; Koks, S.; Kingo, K. ... Franke, A. (2012). Genome-Wide Meta-Analysis of Psoriatic Arthritis Identifies Susceptibility Locus at REL. Journal of Investigative Dermatology, 132 (4), 1133−1140.
 
Rebane, A.; Zimmermann, M.; Aab, A.; Baurecht, H.; Koreck, A.; Karelson, M.; Abram, K.; Metsalu, T.; Pihlap, M.; Meyer, N.; Fölster-Holst, R.; Nagy, N.; Kemeny, L.; Kingo, K.; Vilo, J.; Illig, T.; Akdis, M.; Franke, A.; Novak, N.; Weidinger, S. ... Akdis, CA. (2012). Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. The Journal of Allergy and Clinical Immunology, 129 (5), 1297−306. DOI: 10.1016/j.jaci.2012.02.020.
 
Ellinghaus, D.; Ellinghaus, E.; Nair, RP.; Stuart, PE.; Esko, T.; Metspalu, A.; Debrus, S.; Raelson, JV.; Tejasvi, T.; Belouchi, M.; West, SL.; Barker, JN.; Kõks, S.; Kingo, K.; Balschun, T.; Palmieri, O.; Annese, V.; Gieger, C.; Wichmann, HE.; Kabesch, M. ... Franke, A. (2012). Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci. The American Journal of Human Genetics, 6 (90), 636−647.
 
Karelson, M.; Silm, H.; Salum, T.; Kõks, S.; Kingo, K. (2012). Differences between familial and sporadic cases of vitiligo. Journal of the European Academy of Dermatology and Venereology, 26 (7), 915−918.10.1111/j.1468-3083.2011.04131.x.
 
Douroudis, K.; Kingo, K.; Traks, T.; Reimann, E.; Raud, K.; Rätsep, R.; Mössner, R.; Silm, H.; Vasar, E.; Kõks, S. (2012). Polymorphisms in the ATG16L1 Gene are Associated with Psoriasis Vulgaris. Acta Dermato-Venereologica, 92 (1), 85−87. DOI: 10.2340/00015555-1183.
 
Karelson, M.; Silm, H.; Kingo, K. (2012). Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls. Acta Dermato-Venereologica, 00.
 
Galimova, E.; Akhmetova, V.; Latipov, B.; Kingo, K.; Rätsep, R.; Traks, T.; Kõks, S.; Khusnutdinova, E. (2012). Analysis of genetic variants of class II cytokine and their receptor genes in psoriasis patients of two ethnic groups from the Volga-Ural region of Russia. Journal of Dermatological Science, 68(1), 9−18.
 
Reimann, E.; Kingo, K.; Karelson, M.; Reemann, P.; Loite, U.; Keermann, M.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2012). Expression profile of genes associated with the dopamine pathway in vitiligo skin biopsies and blood sera. Dermatology, 224 (2), 168−176. DOI: 10.1159/000338023.
 
Tsoi, LC; Spain, SL; Knight, J; Ellinghaus, E; Stuart, PE; Capon, F; Ding, J; Li, Y; Tejasvi, T; Gudjonsson, JE; Kang, HM; Allen, MH; McManus, R; Novelli, G; Samuelsson, L; Schalkwijk, J; Ståhle, M; Burden, AD; Smith, CH; Cork, MJ ... Trembath, RC (2012). Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics, 44, 12, 1341−1348. DOI: 10.1038/ng.2467.
 
Kast, J.I.; Wanke, K.; Soyka, M.B.; Wawrzyniak, P.; Akdis, D.; Kingo, K.; Rebane, A.; Akdis, C.A. (2012). The broad spectrum of interepithelial junctions in skin and lung. The Journal of Allergy and Clinical Immunology, 130, 544−547.
 
Douroudis, K.; Kingo, K.; Traks, T.; Rätsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2011). ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis. Human Immunology, 72 (7), 613−615.
 
Douroudis, K.; Sirotkina, M.; Kingo, K.; Mössner, R.; Kõks, S. (2011). Immunohistochemical expression of the PRO2268 protein in psoriasis vulgaris skin. Human Immunology, 72 (6), 522−524.10.1016/j.humimm.2011.03.002.
 
Douroudis, K.; Kingo, K.; Karelson, M.; Silm, H.; Reimann, E.; Traks, T.; Vasar, E.; Kõks, S. (2011). The PRO2268 gene as a novel susceptibility locus for vitiligo. Acta Dermato-Venereologica, 91 (2), 189−191. DOI: 10.2340/00015555-0999.
 
Kingo, K.; Reimann, E.; Karelson, M.; Rätsep, R.; Raud, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Association analysis of genes of the IL19 cluster and their receptors in vitiligo patients. Dermatology, 221 (3, 10), 261−266.
 
Reimann, E.; Kingo, K.; Karelson, M.; Salum, T.; Aunin, E.; Reemann, P.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Analysis of the expression profile of CRH-POMC system genes in vitiligo skin biopsies. Journal of Dermatological Science, 60 (2), 125−128.
 
Douroudis, K.; Kingo, K.; Silm, H.; Reimann, E.; Traks, T.; Vasar, E.; Kõks, S. (2010). The CD226 Gly307Ser gene polymorphism is associated with severity of psoriasis. Journal of Dermatological Science, 58, 160−161.
 
Philips, M-A; Kingo, K; Karelson, M; Rätsep, R; Aunin, E; Reimann, E; Reemann, P; Porosaar, O; Vikeså, J; Nielsen, F; Vasar, E; Silm, H; Kõks, S. (2010). Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1. BMC Medical Genetics, 56. DOI: 10.1186/1471-2350-11-56.
 
Kõks, Sulev; Kingo, Külli; Mössner, Rotraut; Rätsep, Ranno; Krüger, Ullrich; Silm, Helgi; Vasar, Eero; Reich, Kristian; Raud, Kristi; Traks, Tanel; Reimann, Ene (2010). Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis. Journal of Dermatological Science, 57 (1), 71−73. DOI: 10.1016/j.jdermsci.2009.10.007.
 
Koido, K.; Eller, T.; Kingo, K.; Kõks, S.; Traks, T.; Shlik, J.; Vasar, V; Vasar, E.; Maron, E. (2010). Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. Journal of Psychiatric Research, 44 (5), 275−277.10.1016/j.jpsychires.2009.09.001.
 
Traks, T.; Koido, K.; Eller, T.; Maron, E.; Kingo, K.; Vasar, V.; Vasar, E.; Kõks, S. (2008). Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder. BMC Medical Genetics, 9, 111. DOI: 10.1186/1471-2350-9-111.
 
Rätsep, R.; Kingo, K.; Karelson, M.; Reimann, E.; Raud, K.; Silm, H.; Vasar, E.; Kõks, S. (2008). Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera. British Journal of Dermatology, 159 (6), 1275−1281. DOI: 10.1111/j.1365-2133.2008.08785.x.
 
Kingo, K.; Aunin, E.; Karelson, M.; Rätsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2008). Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. Journal of Dermatological Science, 52 (1), 39−46. DOI: 10.1016/j.jdermsci.2008.03.013.
 
Kingo, K.; Mössner, R.; Rätsep, R.; Raud, K.; Krüger, U.; Silm, H.; Vasar, E.; Reich, K.; Kõks, S. (2008). Association analysis of IL20RA and IL20RB genes in psoriasis. Genes and Immunity, 9 (5), 445−451. DOI: 10.1038/gene.2008.36.
 
Kingo, K.; Aunin, E.; Karelson, M.; Philips, MA; Rätsep, R.; Silm, H.; Vasar, E.; Soomets, U.: Kõks S. (2007). Gene expression analysis of melanocortin system in vitiligo. Journal of Dermatological Science, 48 (2), 113−122.
 
Kingo, K.; Mossner, R.; Koks, S.; Ratsep, R.; Kruger, U.; Vasar, E.; Reich, K.; Silm, H. (2007). Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. British Journal of Dermatology, 156 (4), 646−652. DOI: 10.1111/j.1365-2133.2006.07731.x.
 
Kingo, K.; Philips, M.A.; Aunin, E.; Luuk, H.; Karelson, M.; Ratsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2006). MYG1, novel melanocyte related gene, has elevated expression in vitiligo. Journal of Dermatological Science, 44 (2), 119−122.
 
Kingo, K.; Ratsep, R.; Koks, S.; Karelson, M.; Silm, H.; Vasar, E. (2005). Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. Journal of Dermatological Science, 37 (2), 111−113.
 
Mossner, R.; Kingo, K.; Kleensang, A.; Kruger, U.; Konig, IR.; Silm, H.; Westphal, GA.; Reich, K. (2005). Association of TNF-238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. The Journal of Investigative Dermatology, 124 (1), 282−284.
 
Koks, S.; Kingo, K.; Vabrit, K.; Ratsep, R.; Karelson, M.; Silm, H.; Vasar, E. (2005). Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes and Immunity, 6 (5), 407−415.
 
Kingo, K.; Koks, S.; Nikopensius, T.; Silm, H.; Vasar, E. (2004). Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes and Immunity, 5 (2), 117−121.
 
Koks, S.; Kingo, K.; Ratsep, R.; Karelson, M.; Silm, H.; Vasar, E. (2004). Combined haplotype analysis of the interleukin-19 and-20 genes: relationship to plaque-type psoriasis. Genes and Immunity, 5 (8), 662−667.
 
Kingo, K.; Koks, S.; Silm, H.; Vasar, E. (2003). IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes and Immunity, 4 (6), 455−457.
1.2. Teadusartiklid teistes rahvusvahelistes teadusajakirjades, millel on registreeritud kood, rahvusvaheline toimetus, rahvusvahelise kolleegiumiga eelretsenseerimine, rahvusvaheline levik ning kättesaadavus ja avatus kaastöödele
 
Reimann, Ene; Kingo, Külli; Karelson, Maire; Reemann, Paula; Vasar, Eero; Silm, Helgi; Kõks, Sulev (2016). Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients. Dermatopathology, 1 (1), 11−23. DOI: 10.1159/000357402.
 
Karelson, M.; Kingo, K.; Salum, T.; Kõks, S.; Silm, H. (2009). An Adult´s Vitiligo in Estonia: Study of 155 patients. The Open Dermatology Journal, 3, 68−72.
1.3. Eelretsenseeritud teadusartiklid Eesti ja teiste riikide eelretsenseeritavates teadusajakirjades, millel on kohalik toimetuskolleegium, või eelretsenseeritud teadusartiklid Eesti kultuurile olulistes ajakirjades või teadusartiklid ajakirjades Akadeemia, Looming ja Vikerkaar.
 
Šahmatova, Liisi; Abram, Kristi; Kingo, Külli (2014). Dermatoskoopia eestikeelne terminoloogia. Eesti Arst, 349−353.
 
Karelson, M.; Kingo, K.; Silm, H. (2006). Vitiliigo - mis on teada tänasel päeval? Eesti Arst, 85 (7), 438−444.
 
Raudsepp, H.; Kukk, T.; Kingo, K.; Pärna, E.; Rajangu, H.; Tampere, Ma.; Tampere, T.; Topnik, A.; Rannala-Lille, T.; Konno, P.; Dejeva, E.; Tedremets, L.; Kivimägi, K.; Allik, M.; Kesküla, E.; Pohlak, T.; Järna, S.; Mets, H.-R.; Kirsimägi, Ü. (2006). Akne ravi isotretinoiiniga suvekuudel. Eesti Arst, 85 (5), 301−306.
 
Silm, H.; Karelson, M.; Kingo, K.; Järv, H.; Naaber, P. (2003). Küüneseenhaigusesse haigestumise sagedus Eestis. Eesti Arst, 82 (5), 375−378.
 
Silm, H.; Paasik, K.; Kingo, K.; Kink, R. (2002). Vaskaurude laser nahahaiguste ravis. Eesti Arst, 81 (7), 406−410.
2.5. Projekti, tellitud teadustöö või analüüsi publitseeritud raport
 
Briljene, T.; Haldre, K.; Karro, H.; Kingo, K.; Konno, P.; Korrovits, P.; Kukk, T.; Maimets, M.; Part, K.; Punab, M.; Põder, A.; Silm, H.; Szirko, F; Sõritsa, A.; Zilmer K.; Tamm, T.; Tammemäe, L.; Timberg, G. (2015). Seksuaalsel teel levivate infektsioonide ravijuhised Eestis. Seksuaalsel teel levivate infektsioonide ravijuhised Eestis.
3.1. Artiklid/peatükid lisas loetletud kirjastuste välja antud kogumikes (kaasa arvatud Web of Science Book Citation Index, Web of Science Conference Proceedings Citation Index, Scopus refereeritud kogumikud)
 
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2006). Psoriasis and cytokine polymorphisms. In: Vandenbroeck, K. (Ed.). Cytokine Gene Polymorphisms in Multifactorial Conditions (321−335).. CRC Press Inc.
 
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2006). Interleukin-19 subfamily of cytokines. In: Vandenbroeck, K. (Ed.). Cytokine Gene Polymorphisms in Multifactorial Conditions (147−155).. CRC Press Inc.
 
Vasar, E.; Kõks, S.; Kingo, K.; Karelson, M.; Silm, H. (2003). Promoter polymorphism at position-592 of the interleukin-10 is not associated with early- and late-onset psoriasis. Journal of the European Academy of Dermatology and Venereology, 16, Supplement 1: 11th Congress of the European Academy of Dermatology and Venereology. 2-6 October 2002, Prague, Czech Republic. Bologna: Monduzzi Editore, 303−306.
 
Silm, H.; Karelson, M.; Kingo, K. (2001). Mentax 1% Cream in Treatment of Tinea Pedum and Tinea Inguinalis. Skin and Environment - Perception and Protection, 1-2: 10th Congress of the European Academy of Dermatology and Venereology; Munich, Germany; October 10-14, 2001. Ed. Ring, J.; Weidinger, S.; Darsow, U. Bologna: Monduzzi Editore, 281−284.
3.2. Artiklid/peatükid lisas mitte loetletud kirjastuste välja antud kogumikes
 
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2007). Interleukin-20. In: Zdanov, A. (Ed.). Class II Cytokines (145−160).. Research Signpost.
3.4. Artiklid/ettekanded, mis on avaldatud valdkonda 3.1. mittekuuluvates konverentsikogumikes
 
Karelson, M.; Kürsa, V.; Kingo, K.; Silm, H. (2003). Teleangiectasia macularis eruptiva perstans. 11th Congress of the European Academy of Dermatology and Venereology; Prague, Czech Republic; 2-6 October 2002. 93−95.
 
Kingo, K.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2002). Promoter polymorphism at position - 592 of the interleukin-10 is not associated with early and late-onset psoriasis. Proceedings 11th EADV Congress Prague 2002 “ More than Skin – deep” of the European Academy of Dermatology and Venerology, 16:1: Scientific Publishing&Communication. International Proceedings Division, 2003. 303−306.
3.5. Artiklid/ettekanded, mis on avaldatud kohalikes konverentsikogumikes
 
Silm, H.; Karelson, M.; Kaur, S.; Kingo, K. (1998). Lichen ruber Eestis. Arstiteaduskonna aastakonverents (72).. Tartu: TÜ Arstiteaduskond.
4.2. Teiste teadusväljaannete toimetamine, mis ei kuulu kategooriasse 4.1, aga mille väljaandnud kirjastus on akadeemiliselt piisavalt tuntud
 
Altmets, Mait; Altraja, Alan; Ambos, Anu; Andresen, Kadri; Arumäe, Katrin; Brachinsky, Mark; Elmet, Märt; Haldre, Sulev; Hedman, Anu; Kahu, Jaanus; Kaljusaar, Heli; Kallikorm, Riina; Karelson, Maire; Karjagin, Juri; Kaur, Sirje; Kingo, Külli; Koorits, Ursula; Kull, Karin; Kõrv, Janika; Linnamägi, Ülla ... Uuetoa, Tiina (2012). Eakate farmakoteraapia. Tallinn: Medicina.
5.1. Konverentsiteesid, mida kajastab Thomson Reuters Web of Science
 
Kurvits L, Taba P, Planken A, Kadastik-Eerme L, Reimann E, Kõks S, Kingo K (2018). Parkinson’s disease as a multisystem disorder: whole transcriptome study in Parkinson’s disease patients’ skin and blood – finding the pathomechanistic link. European Journal of Neurology, 25 (Suppl2), 126.
 
Lattekivi, F.; Reimann, E.; Keermann, M.; Abram, K.; Koks, S.; Kingo, K.; Fazeli, A. (2017). Multicomponent biomarkers: a novel method for accurate diagnosis of psoriasis. British Journal of Dermatology, 177 (5), E294−E295.
 
Planken, Anu; Kadastik-Eerme, Liis; Kurvits, Lille; Rinken, Siim; Pilv, Jaagup; Reimann, Ene; Kingo, Külli; Kõks, Sulev; Taba, Pille. (2013). Gene expression in skin of Parkinson's disease patients. Movement Disorders, 28 (S1): The MDS 17th International Congress of Parkinson's Disease and Movement Disorders, 16.-20.06.2013, Sydney, Australia. Wiley-Blackwell, S376−S377.
 
Plass, Dietrich; Mangen, Marie-Josée; Havelaar, Arie H; Gibbons, Cheryl; Haagsma, Juanita; Jahn, Beate; Lai, Taavi; van Lier, Alies; Longhi, Silvia; McDonald, Scott A; Kraemer, Alexander; Kramarz, Piotr; Cassini, Alessandro; Kretzschmar, Mirjam E. (2013). The incidence-based and pathogen-based disability-adjusted life-years approach for measuring infectious disease burden in Europe: the Burden of Communicable Diseases in Europe (BCoDE) project. The Lancet, 381, S114. DOI: 10.1016/S0140-6736(13)61368-9.
 
Soomets, U.; Kingo, K.; Mahlapuu, R.; Koks, S. (2011). Antioxidants have possible therapeutic activity for psoriasis. 6th International Congress of Psoriasis - from Gene to Clinic. E28−E28.
5.2. Konverentsiteesid, mis ei kuulu valdkonda 5.1
 
Shunina, Marina; Shahmatova, Liisi; Uibo, Raivo; Kingo, Külli; Kisand, Kai (2016). B cell subpopulations in psoriasis and vitiligo: differences in CD5 and HLA-DR expression. In: .Keystone Symposia - B Cells at the Intersection of Innate and Adaptive Immunity, May 29—June 2, 2016, Stockholm, Sweden.
 
Kärner, J.; Wawrzyniak, M.; Tankov, S.; Runnel, T.; Aints, A.; Kisand, K.; Altraja, A.; Kingo, K.; Akdis, C.; Akdis, M.; Rebane, A. (2016). Increased microRNA-323-3p in IL-22/IL-17-producing T cells and asthma: a role in regulation of the TGF-β pathway and IL-22 production. Eesti Arst, 95(Lisa 2), 37.
 
Šunina, Marina; Šahmatova, Liisi; Kisand, Kai; Uibo, Raivo; Kingo, Külli (2015). The alteration of HLA-DR expression on B cells from vitiligo patients. In: .Be There Or Die? The Role Of The Microenvironment In B Cell Behaviour In Health And Disease; Sant Feliu de Guixols, Spain, 16-21 May 2015.
 
Karelson, M.; Silm, H.; Kingo, K. (2012). Vitiliigohaigete elukvaliteedi ja emotsionaalse seisundi võrdlus psoriaasihaigete ning tervete vabatahtlikega. Eesti Arst: TÜ arstiteaduskonna aastapäeva teaduskonverents, Tartu, oktoober 2012. 23−23.
 
Karelson, Maire; Silm, Helgi; Salum, Tiit; Kõks, Sulev; Kingo, Külli (2011). Differences between familial and sporadic cases of vitiligo. Eesti Arst: Arstiteaduskonna päevad, Tartu, 13-14.okt.2011. 22−22. (90, lisa1).
 
Reimann, E.; Reemann, P.; Lilleoja, R.; Jaakma, Ü.; Kingo, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Whole transcriptome RNA-Seq of human dermal fibroblasts using SOLiD system. CRG Symposium: "Medical Genome Sequencing: Understanding the Genomes of Disease", Barcelona, Spain, 28.-29.10.2010.
 
Kingo, K.; Karelson, M.; Reimann, E.; Rätsep, R.; Vasar, E.; Silm, H.; Kõks, S. (2009). Association analysis of genes of IL19 cluster and their receptors in vitiligo patients. 18th Congress of the European Academy of Dermatology and Venereology (EADV); Berlin, Germany; 7-11 Oct 2009.
 
Oit, I., Mahlapuu, R., Raud, K., Kingo, K., Soomets, U. (2009). Effects of novel glutathione analogues on the expression of antioxidative enzymes. Abstract Book and Program: 5th Conference on Separation and Related Techniques by Nordic Separation Sciemce Society; Tallinn, Estonia; 26-29.08.2009. Ed. Borissova, M., Vaher, M. Infotrükk OÜ, 122.
 
Karelson, M.; Kingo, K.; Silm, H. (2008). Vitiliigo kliinilised vormid ja nende avaldumine. Eesti Arst, 87: TÜ Arstiteaduskonna päevad; Tartu; 9-10.okt 2008. OÜ Celsius Healthcare, 668−668. (9).
 
Oit, I.; Mahlapuu, R.; Raud, K.; Kingo, K.; Soomets, U. (2008). Glutatiooni analoogide mõju psoriaasihaigete mõningate antioksüdantsete ensüümide ekspressioonile. Eesti Arst 87(9): TÜ Arstiteaduskonna päevad; Tartu; 9. oktoober 2008. 670.
 
Karelson, M.; Kingo, K.; Kõks, S.; Vasar, E.; Salum, T.; Silm, H. (2007). Autoimmuunhaiguste kaasnemine ja autoantikehade esinemine vitiliigo haigetel. Eesti Arst, 86, 691.
 
Kingo, K. (2007). Regulation of the Glutathione System in Psoriasis. Abstract Book: BADV 7th Congress, Sept. 6-8, 2007. 64.
 
Kingo, K.; Raud, K.; Rätsep, R.; Kõks, S.; Silm, H.; Vasar, E. (2007). The gene expression of Interleukin-22 in plaque psoriasis. Abstract Book: 21 World Congress of Dermatology; Buenos Aires, Argentina; 01-05.oct. 2007. 203.
 
Pärna, E.; Abram, K.; Kingo, K.; Oona, M.; Silm, H. (2007). Psoriaasihaigete emotsionaalne enesetunne sõltuvalt haiguse raskusest. Eesti Arst, 689−690.
 
Karelson, M.; Kingo, K.; Kõks, S.; Silm, H.; Vasar, E.; Salum, T. (2007). Coexistence of vitiligo and autoimmune disorders in Estonia. Abstract Book: 21 World Congress of Dermatology, Buenos Aires, Argentina, 01-05.oct,2007. 344.
 
Pärna, E.P.; Abram, K.; Kingo, K.; Oona, M.; Silm, H. (2007). Emotional status in psoriasis patients in relation to the sevsrity of disorder. 12th Congress of the European Society for Dermatology and Psychiatry, Wroclaw, Poland, June 14th-17th, 2007. 46.
 
Kingo, K.; Karelson, M.; Aunin, E., Kõks, S.; Vasar, E.; Silm, H. (2006). Expression of Genes of Melanocortin system in Vitiligo. Dermatovenerologie, 51 (3): National Congress of Dermatology with Intyernational Participation. The XIIth ALP-Danube-Adria STD conference; 1- 4 november, 2006. Rumeenia, 2. (Suppl. 1).
 
Kingo, K.; Karelson, M.; Aunin, E.; Silm, H.; Vasar, E.; Kõks, S. (2006). Regulation of the cutaneous corticotropin releasing hormone - proopiomelanocortin systemin vitiligo. BADV 6th Congress; Latvia, Riga; 14 - 16 September, 2006. Ed. Rubins, A. Läti, Riia: Latvia, 41.
 
Raud, K.; Kingo, K.; Ehrlich, K.; Kõks, S.; Silm, H.; Vasar, E.; Soomets, U. (2006). Glutatsioonisüsteemi regulatsioon psoriaasi korral. Eesti Arst, 85 (9): Arstiteaduskonna päevad 2006. 633−634.
 
Philips, M.-A.; Kingo, K.; Kõks, S.; Aunin, E.; Karelson, M.; Silm, H.; Vasar, E. (2006). Myg1 protein is functionally important in both brain and skin. FENS Forum Abstracts, 3: 5th Forum of European Neuroscience; Vienna, Austria; 08 - 12 July, 2006.
 
Kingo, K.; Aunin, E.; Karelson, M.; Rätsep, R.; Philips, M.A.; Luuk, H.; Kõks, S.; Silm, H.; Vasar, E. (2006). Melanokortiini - süsteem ja vitiliigo. Eesti Arst, 85 (9): TÜ arstiteaduskonna teaduskonverents; Tartu; 13.10.2006. , 647.
 
Rätsep, R.; Karelson, M.; Kingo, K.; Aunin, E.; Kõks, S.; Silm, H.; Vasar, E. (2006). Interleukiinide ja nende retseptorite ekspressioon vitiliigoga patsientide ja kontrollgrupi nahas. Eesti Arst, 85(9): TÜ arstiteaduskonna teaduskonverents; Tartu; 13. oktoober 2006. 618.
 
Kingo, K.; Rätsep, R.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Genetic influence on IL-10 expression of patients with plaque type psoriasis. JEADV : Journal of the European Academy of Dermatology and Venereology, 18 (Suppl. 2), 337.
 
Kingo, K.; Rätsep, R.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Association between interleukin-19 and interleukin-20 genetic polymorphisms and plaque-type psoriasis. 16th Congress of Latvian Association of Dermatovenerologists, "Latest Achievements in Skin and Sexually Transmitted Diseases Diagnostics and Therapy"; Riga, Latvia; September 10-11, 2004.
 
Rätsep, R.; Kingo, K.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Interleukiin-19 ja interleukiin-20 geenide haplotüüpide efektid psoriaasi avaldumisele. 625.
 
Kingo, K.; Kõks, S.; Silm, H.; Vasar, E. (2003). Polymorphism in the promoter region of the interleukin-20 gene - relationship to psoriasis vulgaris. JEADV : Journal of the European Academy of Dermatology and Venereology, 17, Suppl. 3, 378.
 
Kingo, Külli; Kõks, Sulev; Silm, Helgi; Vasar, Eero (2003). Interleukiin-20 geneetiliste polümorfismide seos psoriaasiga. Eesti Arst, 9, 631.
 
Silm, H.; Kingo, K.; Paasik, K.; Kink, R. (2002). The efficiency of copper vapour laser equipment for treatment of patients with rosacea. Annales de Dermatologie et de Venereologie, 129, 1S615.
 
Karelson, M.; Kürsa, V.; Kingo, K.; Silm, H. (2002). Teleangiectasia macularis eruptiva perstans. Journal of the European Academy of Dermatology and Venereology, 16, Suppl. 1: 11th Congress of the European Academy of Dermatology and Venereology. Brussels, 198.
 
Silm, H.; Kingo, K.; Väli, M.; Karelson, M. (2001). Alopecia areata in assocation with thyroid diseases. Pediatric Dermatology, 18 (4): Annual Meeting of the Society for Pediatric Dermatology. 98.
 
Silm, H.; Karelson, M.; Kingo, K. (2000). The factors promoting the developing of lichen planus in Estonia. Baltic association of dermatovenereology 3rd congress; Riga, Latvia; September 7-9, 2000. 90.
 
Kingo, K.; Abram, K.; Silm, H. (2000). Pemphigus herpetiformis - the new pemphigus variant. Journal of the European Academy of Dermatology and Venereology, 14, Suppl. 1: 9th Congress of the European Academy of Dermatology and Venereology; 11-15 October 2000; Geneva, Switzerland. , 195.
 
Silm, H.; Kaur, S.; Karelson, M.; Kingo, K. (1998). The factors that promote developing lichen ruber planus in Estonia. Journal of the European Academy of Dermatology and Venereology, 11, Suppl. 2: 7th Congress European Academy of Dermatology and Venereology; France, Nice; 7-11 October 1998. Nice: Elsevier Science BV, S253.
 
Reimann, E.; Kingo, K.; Karelson, M.; Silm, H.; Aunin, E.; Raud, K.; Vasar, E.; Kõks, S. (0). Gene expression study of CRH-POMC system including endogenous opioids in vitiligo skin biopsies and peripheral blood mononuclear cells. Perspectives in Neuroimmunology; Tartu; October 26-28, 2009.
6.2. Õpikud ja muud õppeotstarbelised publikatsioonid, v.a. kõrgkooliõpikud;
 
Kaur, Sirje; Silm, Helgi; Kingo, Külli; Karelson, Maire; Abram, Kristi. (2010). Nahahaigused. Eesti, Tartu ülikooli kirjastus: University of Tartu.
6.3. Populaarteaduslikud artiklid;
 
Kingo, K. (2006). Naastuline psoriaas. Lege Artis, 44−45.
 
Raudsepp, H.; Kukk, T.; Kingo, K.; Pärna, E.; Rajangu, H.; Tampere, M.; Tampere, T.; Topnik, A.; Rannala-Lille, T.; Konno, P.; Dejeva, E.; Tedremets, L.; Kivimägi, K.; Allik, M.t; Kesküla, E.; Pohlak, T.; Järna, S.; Mets, H.-R.; Kirsimägi, Ü. (2006). Akne ravi Rouccutanega suvekuudel. Lege Artis, 28−30.
6.6. Muudes ajakirjades ja ajalehtedes avaldatud artiklid;
 
Kingo, K. (2004). Psoriaas ja geenid. Moodne Meditsiin, 18−19.
 
Silm, H.; Kingo, K. (2003). Esimesed kogemused psoriaasi ravimisel Daivobet salviga. Hippokrates, 45, 431−434.
6.7. Muu loome
 
Silm, Helgi; Kõks, Sulev; Kingo, Külli; Rätsepp, Ranno; Kaur, Sirje; Abram, Kristi; Pärna, Ene; Kingo, Külli; Karelson, Maire (2008). Kliinik 2008 : psoriaasi patogenees ja ravi - kaasaegsed arengusuunad TÜ Nahahaiguste Kliinikus [Videosalvestis]. Kliinik 2008, Tartu Ülikooli Kliinikumi täienduskonverents; Tartu; 4. - 6. veebruar, 2008. Tartu: TÜ IT Multimeedia talitus,. (TÜ filmiarhiiv).
6.8. Lühikirjutised teadusajakirjades ja kogumikes
 
Traks, T; Keermann, M; Karelson, M; Rätsep, R; Reimann, E; Silm, H; Vasar, E; Kõks, S; Kingo, K (2019). Polymorphisms in melanocortin system and MYG1 genes are associated with vitiligo. Journal of the European Academy of Dermatology and Venereology, 33 (2), e65−e67. DOI: 10.1111/jdv.15195.
 
Reemann, Paula; Reimann, Ene; Ilmjärv, Sten; Porosaar, Orm; Silm, Helgi; Jaks, Viljar; Vasar, Eero; Kingo, Külli; Kõks, Sulev (2017). Correction: Melanocytes in the Skin - Comparative Whole Transcriptome Analysis of Main Skin Cell Types. PLoS ONE, 12 (3), e0173792−e0173792. DOI: 10.1371/journal.pone.0173792.
13.04.2021

Külli Kingo

https://www.etis.ee/CV/Külli_Kingo/eng
7.04.1972
731 9706
kylli.kingo@ut.ee
H-3603-2012

Career

Institutions and positions
01.02.2017–...   
University of Tartu, Faculty of Medicine, Institute of Clinical Medicine, Professor in Dermatology and Venereology (1,00)
2012–...   
Tartu University Hospital, Dermatology Clinic of Tartu University Hospital, Head of the Clinic (0,50)
01.01.2010–...   
University of Tartu, Project manager of Estonian Doctoral School of Clinical Medicine (1,00)
2001 – Dermatology Clinic of the Clinics of Tartu University, M.D.
01.02.2017–31.01.2021   
University of Tartu, Faculty of Medicine, Institute of Clinical Medicine, Head of the Clinic (1,00)
01.02.2017–31.12.2019   
University of Tartu, Faculty of Medicine, Vice dean for Science (1,00)
01.01.2016–31.01.2017   
University of Tartu, Faculty of Medicine, Institute of Clinical Medicine, Professor in Dermatology and Venereology (1,00)
01.01.2016–31.01.2017   
University of Tartu, Faculty of Medicine, Vice Dean
01.01.2016–31.01.2017   
University of Tartu, Faculty of Medicine, Institute of Clinical Medicine, Head of Clinic
24.05.2015–31.12.2015   
University of Tartu, Faculty of Medicine, Dean's Office, Vice Dean
01.02.2015–31.12.2015   
University of Tartu, Faculty of Medicine, Department of Dermatology, Head of Clinic
24.05.2012–23.05.2015   
University of Tartu, Faculty of Medicine, Dean's Office, Vice Dean
01.05.2012–31.12.2015   
University of Tartu, Vice dean for Science, Faculty of Medicine, University of Tartu (1,00)
01.02.2012–31.12.2015   
University of Tartu, Faculty of Medicine, Department of Dermatology, Professor in Dermatology and Venereology (1,00)
01.02.2012–31.01.2015   
University of Tartu, Faculty of Medicine, Department of Dermatology, Head of Clinic
01.09.2010–31.01.2012   
University of Tartu, Faculty of Medicine, Department of Dermatology, Head of Clinic
01.09.2008–31.01.2012   
University of Tartu, Faculty of Medicine, Department of Dermatology, Associate Professor in Dermatology and Venereology (0,50)
01.09.2008–31.08.2012   
University of Tartu, Faculty of Medicine, Department of Dermatology, Senior Research Fellow in Dermatology and Venereology (0,50)
01.09.2007–31.08.2008   
University of Tartu, Faculty of Medicine, Department of Dermatology, Senior Research Fellow in Dermatology and Venereology (1,00)
01.02.2007–31.08.2007   
University of Tartu, Faculty of Medicine, Department of Dermatology, Senior Research Fellow extraordinarius (1,00)
2007–2008   
University of Tartu, Faculty of Medicine, Department of Dermatology, Chair of Dermatology and Venerology, Senior Researcher (1,00)
01.09.2005–31.01.2007   
University of Tartu, Faculty of Medicine, Department of Dermatology, Research Fellow (1,00)
01.04.2005–31.08.2005   
University of Tartu, Faculty of Medicine, Department of Dermatology, Specialist (1,00)
01.04.2004–31.03.2005   
University of Tartu, Faculty of Medicine, Department of Dermatology, Research Fellow extraordinarius (1,00)
 
 
Education
1978 – 1990 Tartu Secondary School No 10
1990 – 1996 University of Tartu, Faculty of Medicine (cum laude)
1997 – 2001 University of Tartu, Department of Dermatology, postgraduate student
2001 – 2005 University of Tartu, Department of Dermatology, Ph.D. student
 
 
R&D related managerial and administrative work
2012−...   
Board Member of the European Academy of Dermatology and Venerology
2011−...   
Board Member of the Society for Estonian Dermatologists and Venereologists
2006−...   
Member of the European Academy of Dermatology and Venerology
2003−...   
Member of the Estonian Society Of STD
2003−...   
Member of the Central and East European Dermatovenereologists Association
2001−...   
Member of the Baltic Association of Dermatologists and Venereologists

Qualifications

Academic degrees
Külli Kingo, Doctor's Degree, 2005, (sup) Eero Vasar; Sulev Kõks; Helgi Silm, The interleukin-10 family cytokines gene polymorphisms in plaque psoriasis, University of Tartu, Faculty of Medicine.
 
 
Honours & awards
2016, Külli Kingo, Külli Kingo, Estonian Science Award in Medical Sciences
2004, Külli Kingo, Estonian National Contest for Young Scientists at university level, I Prize
 
 
Fields of research
ETIS CLASSIFICATION: 3. Health; 3.7. Clinical Medicine; SPECIFICATION: The objective of the project is to identify network of genes and biomolecules which are involved in and malfunction of which leads to development chronic dermatoses (psoriasis and vitiligo). Main objectives of the experiments are: 1. Determining functional effects of gene polymorphisms of Class II Helical Cytokines (HCII) and their receptors (HCRII) on psoriasis and vitiligo. 2. Identifying regulatory role of nervous system in development of chronic dermatoses.
 
 
Additional information
Ph.D.
University of Tartu, Faculty of Medicine, 10.06.2005

Projects in progress

Completed projects

Dissertations under supervision

Supervised dissertations

Publications

1.1. Teadusartiklid, mis on kajastatud Web of Science andmebaasides Science Citation Index Expanded, Social Sciences Citation Index, Arts & Humanities Citation Index, Emerging Sources Citation Index ja/või andmebaasis Scopus (v.a. kogumikud)
 
Bodemer C, Kaszuba A, Kingo K, Tsianakas A, Morita A, Rivas E, Papanastasiou P, Keefe D, Patekar M, Charef P, Zhang L, Cafoncelli S, Papavassilis C. (2021). Secukinumab demonstrates high efficacy and a favourable safety profile in paediatric patients with severe chronic plaque psoriasis: 52-week results from a Phase 3 double-blind randomised, controlled trial. Journal of the European Academy of Dermatology and Venereology. DOI: 10.1111/jdv.17002 [ilmumas].
 
Ilves, Liis; Ottas, Aigar; Kaldvee, Bret; Abram, Kristi; Soomets, Ursel; Zilmer, Mihkel; Reemann, Paula; Jaks, Viljar; Kingo, Külli (2021). The metabolomic analysis of skin biopsies from atopic dermatitis patients reveals hallmarks of inflammation, disrupted barrier function and oxidative stress. Acta Dermato-Venereologica, 101 (2). DOI: /doi.org/10.2340/00015555-3766.
 
Frey, Silke; Sticht, Heinrich; Wilsmann-Theis, Dagmar; Gerschütz, Anne; Wolf, Katharina; Löhr, Sabine; Haskamp, Stefan; Frey, Benjamin; Hahn, Madelaine; Ekici, Arif B.; Uebe, Steffen; Thiel, Christian; Reis, André; Burkhardt, Harald; Behrens, Frank; Köhm, Michaela; Rech, Jürgen; Schett, Georg; Assmann, Gunter; Kingo, Külli ... Hüffmeier, Ulrike (2020). Rare Loss-of-Function Mutation in SERPINA3 in Generalized Pustular Psoriasis. Journal of Investigative Dermatology, 13. DOI: 10.1016/j.jid.2019.11.024.
 
Pohla, Liis; Ottas, Aigar; Kaldvee, Bret; Abram, Kristi; Soomets, Ursel; Zilmer, Mihkel; Reemann, Paula; Jaks, Viljar; Kingo, Külli (2020). Hyperproliferation is the main driver of metabolomic changes in psoriasis lesional skin. Scientific Reports, 10 (1), 3081−3081. DOI: 10.1038/s41598-020-59996-z.
 
Saare, Mario; Tserel, Liina; Haljasmägi, Liis; Taalberg, Egon; Peet, Nadežda; Eimre, Margus; Vetik, Rait; Kingo, Külli; Saks, Kai; Tamm, Riin; Milani, Lili; Kisand, Kai; Peterson, Pärt (2020). Monocytes present age-related changes in phospholipid concentration and decreased energy metabolism. Aging Cell, ARTN e13127. DOI: 10.1111/acel.13127.
 
Vaher, Helen; Kivihall, Anet; Runnel, Toomas; Raam, Liisi; Prans, Ele; Maslovskaja, Julia; Abram, Kristi; Kaldvee, Bret; Mrowietz, Ulrich; Weidinger, Stephan; Kingo, Külli; Rebane, Ana (2020). SERPINB2 and miR-146a/b are coordinately regulated and act in the suppression of psoriasis-associated inflammatory responses in keratinocytes. Experimental Dermatology, 29 (1), 51−60. DOI: 10.1111/exd.14049.
 
Augustin, M.; Dauden, E.; Mrowietz, U.; Konstantinou, M. P.; Gerdes, S.; Kingo, K.; Szepietowski, J. C.; Perrot, J. L.; Cuccia, A.; Rissler, M.; Gathmann, S.; Sieder, C.; Orsenigo, R.; Jagiello, P.; Bachhuber, T. (2020). Secukinumab treatment leads to normalization of quality of life and disease symptoms in psoriasis patients with or without prior systemic psoriasis therapy: the PROSE study results. Journal of the European Academy of Dermatology and Venereology. DOI: 10.1111/jdv.16632.
 
Benzian-Olsson N, Dand N, Chaloner C, Bata-Csorgo Z, Borroni R, Burden AD, Cooper HL, Cornelius V, Cro S, Dasandi T, Griffiths CEM, Kingo K, Koks S, Lachmann H, McAteer H, Meynell F, Mrowietz U, Parslew R, Patel P, Pink AE, Reynolds NJ, Tanew A, Torz K, Trattner H, Wahie S, Warren RB, Wright A, Barker JN, Navarini AA, Smith CH, Capon F; ERASPEN consortium and the APRICOT and PLUM study team. (2020). Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis. JAMA Dermatology. DOI: 10.1001/jamadermatol.2020.3275.
 
Twelves S, Mostafa A, Dand N, Burri E, Farkas K, Wilson R, Cooper HL, Irvine AD, Oon HH, Kingo K, Köks S, Mrowietz U, Puig L, Reynolds N, Tan ES, Tanew A, Torz K, Trattner H, Valentine M, Wahie S, Warren RB, Wright A, Bata-Csörgő Z, Szell M, Griffiths CEM, Burden AD, Choon SE, Smith CH, Barker JN, Navarini AA, Capon F. (2019). Clinical and genetic differences between pustular psoriasis subtypes. The Journal of Allergy and Clinical Immunology.10.1016/j.jaci.2018.06.038.
 
Traks, Tanel; Keermann, Maris; Prans, Ele; Karelson, Maire; Loite, Ulvi; Kõks, Gea; Silm, Helgi; Kõks, Sulev; Kingo, Külli (2019). Polymorphisms in IL36G gene are associated with plaque psoriasis. BMC Medical Genetics, 20 (1), 10−10.10.1186/s12881-018-0742-2.
 
Lille Kurvits , Ene Reimann, Liis Kadastik-Eerme, Laura Truu, Külli Kingo, Triin Erm, Sulev Kõks, Pille Taba, Anu Planken (2019). Serum amyloid alpha is downregulated in peripheral tissues of Parkinson’s disease patients. Frontiers in Neuroscience, 13 (13). DOI: 10.3389/fnins.2019.00013.
 
Traks, Tanel; Keermann, Maris; Karelson, Maire; Rätsep, Ranno; Reimann, Ene; Silm, Helgi; Vasar, Eero; Kõks, Sulev; Kingo, Külli (2019). Polymorphisms in Corticotrophin-releasing Hormone-proopiomelanocortin (CRH-POMC) System Genes are Associated with Plaque Psoriasis. Acta Dermato Venereologica. DOI: 10.2340/00015555-3137.
 
van Vugt LJ, van den Reek JMPA, Meulewaeter E, Hakobjan M, Heddes N, Traks T, Kingo K, Galluzzo M, Talamonti M, Lambert J, Coenen MJH, de Jong EMGJ. (2019). Response to IL17A inhibitors secukinumab and ixekizumab cannot be explained by genetic variation in the protein-coding and untranslated regions of the IL17A gene: results from a multicentre study of four European psoriasis cohorts. Journal of the European Academy of Dermatology and Venereology.10.1111/jdv.15787.
 
Reimann, Ene; Abram, Kristi; Koks, Sulev; Kingo, Kulli; Fazeli, Alireza (2019). Identification of an optimal method for extracting RNA from human skin biopsy, using domestic pig as a model system. Scientific Reports, 9, ARTN 20111. DOI: 10.1038/s41598-019-56579-5.
 
Thaci, Diamant; Puig, Lluis; Reich, Kristian; Tsai, Tsen-Fang; Tyring, Stephen; Kingo, Kulli; Ziv, Michael; Pinter, Andreas; Vender, Ronald; Lacombe, Aude; Xia, Summer; Bhosekar, Vaishali; Gilloteau, Isabelle; Guana, Adriana; Blauvelt, Andrew (2019). Secukinumab demonstrates sustained efficacy in clearing skin and improving patient-reported outcomes in patients with moderateto-severe psoriasis through 2 years of treatment: Results from the CLEAR study. Journal of the American Academy of Dermatology, 81 (6), 1405−1409. DOI: 10.1016/j.jaad.2019.04.045.
 
Vaher, Helen; Runnel, Toomas; Urgard, Egon; Aab, Alar; Carreras Badosa, Gemma; Maslovskaja, Julia; Abram, Kristi; Raam, Liisi; Kaldvee, Bret; Annilo, Tarmo; Tkaczyk, Eric R; Maimets, Toivo; Akdis, Cezmi A; Kingo, Külli; Rebane, Ana (2019). miR-10a-5p is increased in atopic dermatitis and has capacity to inhibit keratinocyte proliferation. Allergy, 74 (11), 2146−2156. DOI: 10.1111/all.13849.
 
Reimann, Ene; Lättekivi, Freddy; Keermann, Maris; Abram, Kristi; Kõks, Sulev; Kingo, Külli; Fazeli, Alireza (2019). Multicomponent Biomarker Approach Improves the Accuracy of Diagnostic Biomarkers for Psoriasis Vulgaris. Acta Dermato Venereologica, 99 (13), 1258−1265. DOI: 10.2340/00015555-3337.
 
Lattekivi, Freddy; Kõks, Sulev; Keermann, Maris; Reimann, Ene; Prans, Ele; Abram, Kristi; Silm, Helgi; Kõks, Gea; Kingo, Külli (2018). Transcriptional landscape of human endogenous retroviruses (HERVs) and other repetitive elements in psoriatic skin. Scientific Reports, 8, ARTN 4358. DOI: 10.1038/s41598-018-22734-7.
 
Mössner, R; Wilsmann-Theis, D; Oji, V; Gkogkolou, P; Löhr, S; Schulz, P; Körber, A; Prinz, J C; Renner, R; Schäkel, K; Vogelsang, L; Peters, K-P; Philipp, S; Reich, K; Ständer, H; Jacobi, A; Weyergraf, A; Kingo, K; Kõks, S; Gerdes, S ... Hüffmeier, U (2018). The genetic basis for most patients with pustular skin disease remains elusive. British Journal of Dermatology, 1−9.10.1111/bjd.15867.
 
Carreras-Badosa, Gemma; Runnel, Toomas; Plaas, Mario; Kärner, Jaanika; Rückert, Beate; Lättekivi, Freddy; Kõks, Sulev; Akdis, Cezmi A; Kingo, Külli; Rebane, Ana (2018). microRNA-146a is linked to the production of IgE in mice but not in atopic dermatitis patients. Allergy, 73 (12), 2400−2403. DOI: 10.1111/all.13579.
 
Raam, Liisi; Kaleviste, Epp; Sunina, Marina; Vaher, Helen; Saare, Mario; Prans, Ele; Pihlap, Maire; Abram, Kristi; Karelson, Maire; Peterson, Part; Rebane, Ana; Kisand, Kai; Kingo, Kulli (2018). Lymphoid Stress Surveillance Response Contributes to Vitiligo Pathogenesis. Frontiers in Immunology, 9, ARTN 2707. DOI: 10.3389/fimmu.2018.02707.
 
Kärner, J; Wawrzyniak, M; Tankov, S; Runnel, T; Aints, A; Kisand, K; Altraja, A; Kingo, K; Akdis, C A; Akdis, M; Rebane, A (2017). Increased microRNA-323-3p in IL-22/IL-17-producing T cells and asthma: a role in the regulation of the TGF-β pathway and IL-22 production. Allergy, 72 (1), 55−65.10.1111/all.12907.
 
Kõks, Sulev; Keermann, Maris; Reimann, Ene; Prans, Ele; Abram, Kristi; Silm, Helgi; Kõks, Gea; Kingo, Kulli (2017). Psoriasis-Specific RNA Isoforms Identified by RNA-Seq Analysis of 173,446 Transcripts. Frontiers in Medicine, 3, 46. DOI: 10.3389/fmed.2016.00046.
 
Ottas, Aigar; Fishman, Dmytro; Okas, Tiia-Linda; Kingo, Külli; Soomets, Ursel; (2017).

The metabolic analysis of psoriasis identifies the associated metabolites while providing computational models for the monitoring of the disease

. Archives of Dermatological Research, 309 (7), 519−528.10.1007/s00403-017-1760-1.
 
Planken, A.; Kurvits, L.; Reimann, E.; Kadastik-Eerme, L.; Kingo, K.; Kõks, S.; Taba, P.; (2017). Looking beyond the brain to improve the pathogenic understanding of Parkinson's disease: Implications of whole transcriptome profiling of Patients' skin. BMC Neurology, 17 (6), 6−6. DOI: 10.1186/s12883-016-0784-z.
 
Navarini, A A; Burden, A D; Capon, F; Mrowietz, U; Puig, L; Köks, S; Kingo, K; Smith, C; Barker, J N; , (2017). European consensus statement on phenotypes of pustular psoriasis. Journal of the European Academy of Dermatology and Venereology, 31 (11), 1792−1799.10.1111/jdv.14386.
 
Tsoi, Lam C.; Stuart, Philip E.; Tian, Chao; Gudjonsson, Johann E.; Das, Sayantan; Zawistowski, Matthew; Ellinghaus, Eva; Barker, Jonathan N.; Chandran, Vinod; Dand, Nick; Duffin, Kristina Callis; Enerback, Charlotta; Esko, Tonu; Franke, Andre; Gladman, Dafna D.; Hoffmann, Per; Kingo, Kulli; Koks, Sulev; Krueger, Gerald G.; Lim, Henry W. ... Elder, James T. (2017). Large scale meta-analysis characterizes genetic architecture for common psoriasis associated variants. Nature Communications, 8, ARTN 15382. DOI: 10.1038/ncomms15382.
 
Griffiths CEM, Thaci D, Gerdes S, Arenberger P, Pulka G, Kingo K, Weglowska J, EGALITY study group, Hattebuhr N, Poetzl J, Woehling H, Wuerth G, Afonso M. (2017). The EGALITY study: a confirmatory, randomized, double-blind stydy comparing the efficacy, safety and immunogenicity of GP2015, a proposed etanercept biosimilar, vs. the originator product in patients with moderate-to-severe chronic plaque-type psoriasis. British Journal of Dermatology, 176 (4), 928−938.10.1111/bjd.15152.
 
Blauvelt, A, Reich K, Tsai TF, Tyring S, Vanaclocha F, Kingo K, Ziv M, Pinter A, Vender R, Hugot S, You R, Milutinovic M, Thaçi D. (2017). Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate-to-severe plaque psoriasis up to 1 year: Results from the CLEAR study. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 76 (1), 60−69.10.1016/j.jaad.2016.08.008.
 
Khobzey K, Liskova I, Szegedi A, Pavlovsky L, Lunder T, Kingo K, Miljković J, Péč J, Bohinc M, Hojnik M. (2017). Effectiveness of adalimumab in the treatment of scalp and nail affection in patients with moderate to severe plaque psoriasis in routine clinical practice. Acta Dermatovenerologica Alpina, Pannonica et Adriatica, 26, 1, 11−14.
 
Galimova, E.; Khusnutdinova, E.; Rätsep, R.; Traks, T.; Kingo, K.; Escott-Price, V.; Kõks, S. (2017). Interleukin-10 family cytokines pathway: genetic variants and psoriasis. British Journal of Dermatology, 1−14.10.1111/bjd.15363.
 
Šahmatova, Liisi; Sügis, Elena; Šunina, Marina; Hermann, Helen; Prans, Ele; Pihlap, Maire; Abram, Kristi; Rebane, Ana; Peterson, Hedi; Peterson, Pärt; Kingo, Külli; Kisand, Kai (2017). Signs of innate immune activation and premature immunosenescence in psoriasis patients. Scientific Reports, 7 (1), 7553−7553. DOI: 10.1038/s41598-017-07975-2.
 
Ottas, Aigar; Fishman, Dmytro; Okas, Tiia-Linda; Pussa, Tonu; Toomik, Peeter; Martson, Aare; Kingo, Kulli; Soomets, Ursel (2017).

Blood serum metabolome of atopic dermatitis: Altered energy cycle and the markers of systemic inflammation

. PLoS ONE, 12 (11), ARTN e0188580. DOI: 10.1371/journal.pone.0188580.
 
Traks, Tanel; Karelson, Maire; Reimann, Ene; Rätsep, Ranno; Silm, Helgi; Vasar, Eero; Kõks, Sulev; Kingo, Külli (2016). Association analysis of class II cytokine and receptor genes in vitiligo patients. Human Immunology, 77 (5), 375−381.10.1016/j.humimm.2015.09.050.
 
Šahmatova, Liisi; Tankov, Stoyan; Prans, Ele; Aab, Alar; Hermann, Helen; Reemann, Paula; Pihlap, Maire; Karelson, Maire; Abram, Kristi; Kisand, Kai; Kingo, Külli; Rebane, Ana (2016). MicroRNA-155 is Dysregulated in the Skin of Patients with Vitiligo and Inhibits Melanogenesis-associated Genes in Melanocytes and Keratinocytes. Acta Dermato Venereologica, 96, 6, 742−747. DOI: 10.2340/00015555-2394.
 
Urgard, Egon; Lorents, Annely; Klaas, Mariliis; Padari, Kärt; Viil, Janeli; Runnel, Toomas; Langel, Kent; Kingo, Külli; Tkaczyk, Eric; Langel, Ülo; Maimets, Toivo; Jaks, Viljar; Pooga, Margus; Rebane, Ana (2016). Pre-administration of PepFect6-microRNA-146a nanocomplexes inhibits inflammatory responses in keratinocytes and in a mouse model of irritant contact dermatitis. Journal of Controlled Release, 235, 195−2014. DOI: 10.1016/j.jconrel.2016.06.006.
 
Jin, Ying; Andersen, Genevieve; Yorgov, Daniel; Ferrara, Tracey M.; Ben, Songtao; Brownson, Kelly M.; Holland, Paulene J.; Birlea, Stanca A.; Siebert, Janet; Hartmann, Anke; Lienert, Anne; van Geel, Nanja; Lambert, Jo; Luiten, Rosalie M.; Wolkerstorfer, Albert; van der Veen, J. P. Wietze; Bennett, Dorothy C.; Taieb, Alain; Ezzedine, Khaled; Kemp, E. Helen ... Spritz, Richard A. (2016). Genome-wide association studies of autoimmune vitiligo identify 23 new risk loci and highlight key pathways and regulatory variants. Nature Genetics, 48 (11), 1418−1424. DOI: 10.1038/ng.3680.
 
Mägi, A; Unt, E; Prans, E; Raus, L;Eha, J; Veraksitš, A; Kingo, K; Kõks, S. (2016). The association analysis between ACE and ACTN3 genes polymorphisms and endurance capacity in young cross-country skiers: longitudinal study. Journal of Sports Science and Medicine, 15 (2), 287−294.
 
Simpson EL, Bieber T, Guttman-Yassky E, Beck LA, Blauvelt A, Cork MJ, Silverberg JI, Deleuran M, Kataoka Y, Lacour JP, Kingo K, Worm M, Poulin Y, Wollenberg A, Soo Y, Graham NM, Pirozzi G, Akinlade B, Staudinger H, Mastey V, Eckert L, Gadkari A, Stahl N, Yancopoulos GD, Ardeleanu M; SOLO 1 and SOLO 2 Investigators. (2016). Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis. New England Journal of Medicine, 375 (24), 2335−2348.10.1056/NEJMoa1610020.
 
Blauvelt A, Prinz JC, Gottlieb AB, Kingo K, et al. (2015). Secukinumab administration by pre-filled syringe: efficacy, safety and usability results from a randomized controlled trial in psoriasis (FEATURE). British Journal of Dermatology, 172 (2), 484−493.10.1111/bjd.13348.
 
Mössner R, Frambach Y, Wilsmann-Theis D, Kingo K, et al (2015). Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients. Journal of Investigative Dermatology, 135 (10), 2538−2541.10.1038/jid.2015.186.
 
Thaçi D, Blauvelt A, Reich K, Tsai TF, Vanaclocha F, Kingo K, et al (2015). Secukinumab is superior to ustekinumab in clearing skin of subjects with moderate to severe plaque psoriasis: CLEAR, a randomized controlled trial. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 73 (3), 400−409.10.1016/j.jaad.2015.05.013.
 
Traks T, Keermann M, Karelson M, Rätsep R, Reimann E, Silm H, Vasar E, Kõks S, Kingo K. (2015). Polymorphisms in Toll-like receptor genes are associated with vitiligo. Frontiers in Genetics, 6, x−x. DOI: 10.3389/fgene.2015.00278.
 
Keermann, Maris; Kõks, Sulev; Reimann, Ene; Abram, Kristi; Erm, Triin; Silm, Helgi; Kingo, Külli (2015). Expression of IL-36 family cytokines and IL-37 but not IL-38 is altered in psoriatic skin. Journal of Dermatological Science, 80 (2), 150−152. DOI: 10.1016/j.jdermsci.2015.08.002.
 
Tsoi, L. C.; Spain, S. L.; Ellinghaus, E.; Stuart, P. E.; Capon, F.; Knight, J.; Tejasvi, T.; Kang, H. M.; Allen, M. H.; Lambert, S.; Stoll, S. W.; Weidinger, S.; Gudjonsson, J. E.; Kõks, S.; Kingo, K.; Esko, T.; Das, S.; Metspalu, A.; Weichenthal, M.; Enerback, C. ... Elder, J. T. (2015). Enhanced meta-analysis and replication studies identify five new psoriasis susceptibility loci. Nature Communications, 6 (7001), 1−8. DOI: 10.1038/ncomms8001.
 
Pärna, E.; Aluoja, A.; Kingo, K. (2015). Quality of Life and Emotional State in Chronic Skin Disease. Acta Dermato-Venereologica, 95 (3), 312−316.10.2340/00015555-1920.
 
Stuart, P. E.; Nair, R. P.; Tsoi, L. C.; Tejasvi, T.; Das, S.; Kang, H. M.; Ellinghaus, E.; Chandran, V.; Callis-Duffin, K.; Ike, R.; Li, Y. M.; Wen, X. Q.; Enerback, C.; Gudjonsson, J. E.; Kõks, S.; Kingo, K.; Esko, T.; Mrowietz, U.; Reis, A.; Wichmann, H. E. ... Elder, J. T. (2015). Genome-wide Association Analysis of Psoriatic Arthritis and Cutaneous Psoriasis Reveals Differences in Their Genetic Architecture. The American Journal of Human Genetics, 97 (6), 816−836.10.1016/j.ajhg.2015.10.019.
 
Mössner, R.; Frambach, Y.; Wilsmann-Theis, D.; Löhr, S.; Jacobi, A.; Weyergraf, A.; Müller, M.; Philipp, S.; Renner, R.; Traupe, H.; Burkhardt, H.; Kingo, K.; Kõks, S.; Uebe, S.; Sticherling, M.; Sticht, H.; Oji, V.; Hüffmeier U. (2015). Palmoplantar pustular psoriasis is associated with missense variants in CARD14, but not with loss-of-function mutations in IL36RN in European patients. Journal of Investigative Dermatology, 135, 10, 2538−2541.
 
Keermann, M.; Kõks, S.; Reimann, E.; Prans, E.; Abram, K.; Kingo, K. (2015). Transcriptional landscape of psoriasis identifies the involvement of IL36 and IL36RN. BMC Genomics, 16, 322−333. DOI: 10.1186/s12864-015-1508-2.
 
Langley RG, Elewski BE, Lebwohl M, Reich K, ERASURE Study Group, FIXTURE Study Group. (2014). Secukinumab in plaque psoriasis--results of two phase 3 trials. New England Journal of Medicine, 371 (4), 326−338.10.1056/NEJMoa1314258.
 
Reemann, P.; Reimann, E.; Ilmjärv, S.; Porosaar, O.; Silm, H.; Jaks, V.; Vasar, E.; Kingo, K.; Kõks, S. (2014). Melanocytes in the skin - comparative whole transcriptome analysis of main skin cell types. PLoS ONE, 9 (12), e115717. DOI: 10.1371/journal.pone.0115717.
 
Siimon, Kaido; Reemann, Paula; Poder, Annika; Pook, Martin; Kangur, Triin; Kingo, Kulli; Jaks, Viljar; Maeorg, Uno; Jaervekuelg, Martin (2014). Effect of glucose content on thermally cross-linked fibrous gelatin scaffolds for tissue engineering. Materials Science and Engineering C, 42, 538−545. DOI: 10.1016/j.msec.2014.05.075.
 
Reemann, Paula; Reimann, Ene; Suutre, Siim; Paavo, Maarjaliis; Loite, Ulvi; Porosaar, Orm; Abram, Kristi; Silm, Helgi; Vasar, Eero; Koks, Sulev; Kingo, Kuelli (2014). Expression of Class II Cytokine Genes in Children's Skin. Acta Dermato-Venereologica, 94 (4), 386−392. DOI: 10.2340/00015555-1717.
 
Orro, Kadri; Smirnova, Olga; Arshavskaja, Jelena; Salk, Kristiina; Meikas, Anne; Pihelgas, Susan; Rumvolt, Reet; Kingo, Külli; Kazarjan, Aram; Neuman, Toomas; Spee, Pieter (2014). Development of TAP, a non-invasive test for qualitative and quantitative measurements of biomarkers from the skin surface. Biomarker Research, 2 (20), #20.10.1186/2050-7771-2-20.
 
Rebane, Ana; Runnel, Toomas; Aab, Alar; Maslovskaja, Julia; Rueckert, Beate; Zimmermann, Maya; Plaas, Mario; Käner, Jaanika; Treis, Angela; Pihlap, Maire; Haljasorg, Uku; Hermann, Helen; Nagy, Nikoletta; Kemeny, Lajos; Erm, Triin; Kingo, Külli; Li, Mei; Boldin, Mark P.; Akdis, Cezmi A. (2014). MicroRNA-146a alleviates chronic skin inflammation in atopic dermatitis through suppression of innate immune responses in keratinocytes. Journal of Allergy and Clinical Immunology, 134 (4), 836−859. DOI: 10.1016/j.jaci.2014.05.022.
 
Karelson, M.; Silm, H.; Kingo, K. (2013). Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls. Acta Dermato-Venereologica, 93, 446−450.
 
Reemann, Paula; Kangur, Triin; Pook, Martin; Paalo, Madis; Nurmis, Liis; Kink, Ilmar; Porosaar, Orm; Kingo, Külli; Vasar, Eero; Kõks, Sulev; Jaks, Viljar; Järvekülg, Martin (2013). Fibroblast growth on micro- and nanopatterned surfaces prepared by a novel sol-gel phase separation method. Journal of Materials Science Materials in Medicine, 24 (3), 783−792. DOI: 10.1007/s10856-012-4829-6.
 
Loite, U; Kingo, K; Reimann, E; Reemann, P; Vasar, E; Silm, H; Kõks, S. (2013). Gene Expression Analysis of the Corticotrophin-releasing Hormone-proopiomelanocortin System in Psoriasis Skin Biopsies. Acta Dermato-Venereologica, 93 (4), 400−405. DOI: 10.2340/00015555-1524.
 
Prans, Ele; Kingo, Külli; Traks, Tanel; Silm, Helgi; Vasar, Eero; Kõks, Sulev (2013). Copy number variations in IL22 gene are associated with psoriasis vulgaris. Human Immunology, 74 (6), 792−795.10.1016/j.humimm.2013.01.006.
 
Reimann, E.; Kingo, K.; Karelson, M.; Reemann, P.; Loite, U.; Sulakatko, H.; Keermann, M.; Raud, K.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2012). The mRNA expression profile of cytokines connected to the regulation of melanocyte functioning in vitiligo skin biopsy samples and peripheral blood mononuclear cells. Human Immunology, 73 (4), 393−398. DOI: 10.1016/j.humimm.2012.01.011.
 
Ellinghaus, E.; Stuart, PE.; Ellinghaus, D.; Nair, RP.; Debrus, S.; Raelson, JV.; Belouchi, M.; Tejasvi, T.; Li, Y.; Tsoi, LC.; Onken, AT.; Esko, T.; Metspalu, A.; Rahman, P.; Gladman, DD.; Bowcock, AM.; Helms, C.; Krueger, GG.; Koks, S.; Kingo, K. ... Franke, A. (2012). Genome-Wide Meta-Analysis of Psoriatic Arthritis Identifies Susceptibility Locus at REL. Journal of Investigative Dermatology, 132 (4), 1133−1140.
 
Rebane, A.; Zimmermann, M.; Aab, A.; Baurecht, H.; Koreck, A.; Karelson, M.; Abram, K.; Metsalu, T.; Pihlap, M.; Meyer, N.; Fölster-Holst, R.; Nagy, N.; Kemeny, L.; Kingo, K.; Vilo, J.; Illig, T.; Akdis, M.; Franke, A.; Novak, N.; Weidinger, S. ... Akdis, CA. (2012). Mechanisms of IFN-γ-induced apoptosis of human skin keratinocytes in patients with atopic dermatitis. The Journal of Allergy and Clinical Immunology, 129 (5), 1297−306. DOI: 10.1016/j.jaci.2012.02.020.
 
Ellinghaus, D.; Ellinghaus, E.; Nair, RP.; Stuart, PE.; Esko, T.; Metspalu, A.; Debrus, S.; Raelson, JV.; Tejasvi, T.; Belouchi, M.; West, SL.; Barker, JN.; Kõks, S.; Kingo, K.; Balschun, T.; Palmieri, O.; Annese, V.; Gieger, C.; Wichmann, HE.; Kabesch, M. ... Franke, A. (2012). Combined Analysis of Genome-wide Association Studies for Crohn Disease and Psoriasis Identifies Seven Shared Susceptibility Loci. The American Journal of Human Genetics, 6 (90), 636−647.
 
Karelson, M.; Silm, H.; Salum, T.; Kõks, S.; Kingo, K. (2012). Differences between familial and sporadic cases of vitiligo. Journal of the European Academy of Dermatology and Venereology, 26 (7), 915−918.10.1111/j.1468-3083.2011.04131.x.
 
Douroudis, K.; Kingo, K.; Traks, T.; Reimann, E.; Raud, K.; Rätsep, R.; Mössner, R.; Silm, H.; Vasar, E.; Kõks, S. (2012). Polymorphisms in the ATG16L1 Gene are Associated with Psoriasis Vulgaris. Acta Dermato-Venereologica, 92 (1), 85−87. DOI: 10.2340/00015555-1183.
 
Karelson, M.; Silm, H.; Kingo, K. (2012). Quality of Life and Emotional State in Vitiligo in an Estonian Sample: Comparison with Psoriasis and Healthy Controls. Acta Dermato-Venereologica, 00.
 
Galimova, E.; Akhmetova, V.; Latipov, B.; Kingo, K.; Rätsep, R.; Traks, T.; Kõks, S.; Khusnutdinova, E. (2012). Analysis of genetic variants of class II cytokine and their receptor genes in psoriasis patients of two ethnic groups from the Volga-Ural region of Russia. Journal of Dermatological Science, 68(1), 9−18.
 
Reimann, E.; Kingo, K.; Karelson, M.; Reemann, P.; Loite, U.; Keermann, M.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2012). Expression profile of genes associated with the dopamine pathway in vitiligo skin biopsies and blood sera. Dermatology, 224 (2), 168−176. DOI: 10.1159/000338023.
 
Tsoi, LC; Spain, SL; Knight, J; Ellinghaus, E; Stuart, PE; Capon, F; Ding, J; Li, Y; Tejasvi, T; Gudjonsson, JE; Kang, HM; Allen, MH; McManus, R; Novelli, G; Samuelsson, L; Schalkwijk, J; Ståhle, M; Burden, AD; Smith, CH; Cork, MJ ... Trembath, RC (2012). Identification of 15 new psoriasis susceptibility loci highlights the role of innate immunity. Nature Genetics, 44, 12, 1341−1348. DOI: 10.1038/ng.2467.
 
Kast, J.I.; Wanke, K.; Soyka, M.B.; Wawrzyniak, P.; Akdis, D.; Kingo, K.; Rebane, A.; Akdis, C.A. (2012). The broad spectrum of interepithelial junctions in skin and lung. The Journal of Allergy and Clinical Immunology, 130, 544−547.
 
Douroudis, K.; Kingo, K.; Traks, T.; Rätsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2011). ATG16L1 gene polymorphisms are associated with palmoplantar pustulosis. Human Immunology, 72 (7), 613−615.
 
Douroudis, K.; Sirotkina, M.; Kingo, K.; Mössner, R.; Kõks, S. (2011). Immunohistochemical expression of the PRO2268 protein in psoriasis vulgaris skin. Human Immunology, 72 (6), 522−524.10.1016/j.humimm.2011.03.002.
 
Douroudis, K.; Kingo, K.; Karelson, M.; Silm, H.; Reimann, E.; Traks, T.; Vasar, E.; Kõks, S. (2011). The PRO2268 gene as a novel susceptibility locus for vitiligo. Acta Dermato-Venereologica, 91 (2), 189−191. DOI: 10.2340/00015555-0999.
 
Kingo, K.; Reimann, E.; Karelson, M.; Rätsep, R.; Raud, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Association analysis of genes of the IL19 cluster and their receptors in vitiligo patients. Dermatology, 221 (3, 10), 261−266.
 
Reimann, E.; Kingo, K.; Karelson, M.; Salum, T.; Aunin, E.; Reemann, P.; Abram, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Analysis of the expression profile of CRH-POMC system genes in vitiligo skin biopsies. Journal of Dermatological Science, 60 (2), 125−128.
 
Douroudis, K.; Kingo, K.; Silm, H.; Reimann, E.; Traks, T.; Vasar, E.; Kõks, S. (2010). The CD226 Gly307Ser gene polymorphism is associated with severity of psoriasis. Journal of Dermatological Science, 58, 160−161.
 
Philips, M-A; Kingo, K; Karelson, M; Rätsep, R; Aunin, E; Reimann, E; Reemann, P; Porosaar, O; Vikeså, J; Nielsen, F; Vasar, E; Silm, H; Kõks, S. (2010). Promoter polymorphism -119C/G in MYG1 (C12orf10) gene is related to vitiligo susceptibility and Arg4Gln affects mitochondrial entrance of Myg1. BMC Medical Genetics, 56. DOI: 10.1186/1471-2350-11-56.
 
Kõks, Sulev; Kingo, Külli; Mössner, Rotraut; Rätsep, Ranno; Krüger, Ullrich; Silm, Helgi; Vasar, Eero; Reich, Kristian; Raud, Kristi; Traks, Tanel; Reimann, Ene (2010). Further association analysis of chr 6q22-24 suggests a role of IL-20RA polymorphisms in psoriasis. Journal of Dermatological Science, 57 (1), 71−73. DOI: 10.1016/j.jdermsci.2009.10.007.
 
Koido, K.; Eller, T.; Kingo, K.; Kõks, S.; Traks, T.; Shlik, J.; Vasar, V; Vasar, E.; Maron, E. (2010). Interleukin 10 family gene polymorphisms are not associated with major depressive disorder and panic disorder phenotypes. Journal of Psychiatric Research, 44 (5), 275−277.10.1016/j.jpsychires.2009.09.001.
 
Traks, T.; Koido, K.; Eller, T.; Maron, E.; Kingo, K.; Vasar, V.; Vasar, E.; Kõks, S. (2008). Polymorphisms in the interleukin-10 gene cluster are possibly involved in the increased risk for major depressive disorder. BMC Medical Genetics, 9, 111. DOI: 10.1186/1471-2350-9-111.
 
Rätsep, R.; Kingo, K.; Karelson, M.; Reimann, E.; Raud, K.; Silm, H.; Vasar, E.; Kõks, S. (2008). Gene expression study of IL10 family genes in vitiligo skin biopsies, peripheral blood mononuclear cells and sera. British Journal of Dermatology, 159 (6), 1275−1281. DOI: 10.1111/j.1365-2133.2008.08785.x.
 
Kingo, K.; Aunin, E.; Karelson, M.; Rätsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2008). Expressional changes in the intracellular melanogenesis pathways and their possible role in the pathogenesis of vitiligo. Journal of Dermatological Science, 52 (1), 39−46. DOI: 10.1016/j.jdermsci.2008.03.013.
 
Kingo, K.; Mössner, R.; Rätsep, R.; Raud, K.; Krüger, U.; Silm, H.; Vasar, E.; Reich, K.; Kõks, S. (2008). Association analysis of IL20RA and IL20RB genes in psoriasis. Genes and Immunity, 9 (5), 445−451. DOI: 10.1038/gene.2008.36.
 
Kingo, K.; Aunin, E.; Karelson, M.; Philips, MA; Rätsep, R.; Silm, H.; Vasar, E.; Soomets, U.: Kõks S. (2007). Gene expression analysis of melanocortin system in vitiligo. Journal of Dermatological Science, 48 (2), 113−122.
 
Kingo, K.; Mossner, R.; Koks, S.; Ratsep, R.; Kruger, U.; Vasar, E.; Reich, K.; Silm, H. (2007). Association analysis of IL19, IL20 and IL24 genes in palmoplantar pustulosis. British Journal of Dermatology, 156 (4), 646−652. DOI: 10.1111/j.1365-2133.2006.07731.x.
 
Kingo, K.; Philips, M.A.; Aunin, E.; Luuk, H.; Karelson, M.; Ratsep, R.; Silm, H.; Vasar, E.; Kõks, S. (2006). MYG1, novel melanocyte related gene, has elevated expression in vitiligo. Journal of Dermatological Science, 44 (2), 119−122.
 
Kingo, K.; Ratsep, R.; Koks, S.; Karelson, M.; Silm, H.; Vasar, E. (2005). Influence of genetic polymorphisms on interleukin-10 mRNA expression and psoriasis susceptibility. Journal of Dermatological Science, 37 (2), 111−113.
 
Mossner, R.; Kingo, K.; Kleensang, A.; Kruger, U.; Konig, IR.; Silm, H.; Westphal, GA.; Reich, K. (2005). Association of TNF-238 and -308 promoter polymorphisms with psoriasis vulgaris and psoriatic arthritis but not with pustulosis palmoplantaris. The Journal of Investigative Dermatology, 124 (1), 282−284.
 
Koks, S.; Kingo, K.; Vabrit, K.; Ratsep, R.; Karelson, M.; Silm, H.; Vasar, E. (2005). Possible relations between the polymorphisms of the cytokines IL-19, IL-20 and IL-24 and plaque-type psoriasis. Genes and Immunity, 6 (5), 407−415.
 
Kingo, K.; Koks, S.; Nikopensius, T.; Silm, H.; Vasar, E. (2004). Polymorphisms in the interleukin-20 gene: relationships to plaque-type psoriasis. Genes and Immunity, 5 (2), 117−121.
 
Koks, S.; Kingo, K.; Ratsep, R.; Karelson, M.; Silm, H.; Vasar, E. (2004). Combined haplotype analysis of the interleukin-19 and-20 genes: relationship to plaque-type psoriasis. Genes and Immunity, 5 (8), 662−667.
 
Kingo, K.; Koks, S.; Silm, H.; Vasar, E. (2003). IL-10 promoter polymorphisms influence disease severity and course in psoriasis. Genes and Immunity, 4 (6), 455−457.
1.2. Teadusartiklid teistes rahvusvahelistes teadusajakirjades, millel on registreeritud kood, rahvusvaheline toimetus, rahvusvahelise kolleegiumiga eelretsenseerimine, rahvusvaheline levik ning kättesaadavus ja avatus kaastöödele
 
Reimann, Ene; Kingo, Külli; Karelson, Maire; Reemann, Paula; Vasar, Eero; Silm, Helgi; Kõks, Sulev (2016). Whole Transcriptome Analysis (RNA Sequencing) of Peripheral Blood Mononuclear Cells of Vitiligo Patients. Dermatopathology, 1 (1), 11−23. DOI: 10.1159/000357402.
 
Karelson, M.; Kingo, K.; Salum, T.; Kõks, S.; Silm, H. (2009). An Adult´s Vitiligo in Estonia: Study of 155 patients. The Open Dermatology Journal, 3, 68−72.
1.3. Eelretsenseeritud teadusartiklid Eesti ja teiste riikide eelretsenseeritavates teadusajakirjades, millel on kohalik toimetuskolleegium, või eelretsenseeritud teadusartiklid Eesti kultuurile olulistes ajakirjades või teadusartiklid ajakirjades Akadeemia, Looming ja Vikerkaar.
 
Šahmatova, Liisi; Abram, Kristi; Kingo, Külli (2014). Dermatoskoopia eestikeelne terminoloogia. Eesti Arst, 349−353.
 
Karelson, M.; Kingo, K.; Silm, H. (2006). Vitiliigo - mis on teada tänasel päeval? Eesti Arst, 85 (7), 438−444.
 
Raudsepp, H.; Kukk, T.; Kingo, K.; Pärna, E.; Rajangu, H.; Tampere, Ma.; Tampere, T.; Topnik, A.; Rannala-Lille, T.; Konno, P.; Dejeva, E.; Tedremets, L.; Kivimägi, K.; Allik, M.; Kesküla, E.; Pohlak, T.; Järna, S.; Mets, H.-R.; Kirsimägi, Ü. (2006). Akne ravi isotretinoiiniga suvekuudel. Eesti Arst, 85 (5), 301−306.
 
Silm, H.; Karelson, M.; Kingo, K.; Järv, H.; Naaber, P. (2003). Küüneseenhaigusesse haigestumise sagedus Eestis. Eesti Arst, 82 (5), 375−378.
 
Silm, H.; Paasik, K.; Kingo, K.; Kink, R. (2002). Vaskaurude laser nahahaiguste ravis. Eesti Arst, 81 (7), 406−410.
2.5. Projekti, tellitud teadustöö või analüüsi publitseeritud raport
 
Briljene, T.; Haldre, K.; Karro, H.; Kingo, K.; Konno, P.; Korrovits, P.; Kukk, T.; Maimets, M.; Part, K.; Punab, M.; Põder, A.; Silm, H.; Szirko, F; Sõritsa, A.; Zilmer K.; Tamm, T.; Tammemäe, L.; Timberg, G. (2015). Seksuaalsel teel levivate infektsioonide ravijuhised Eestis. Seksuaalsel teel levivate infektsioonide ravijuhised Eestis.
3.1. Artiklid/peatükid lisas loetletud kirjastuste välja antud kogumikes (kaasa arvatud Web of Science Book Citation Index, Web of Science Conference Proceedings Citation Index, Scopus refereeritud kogumikud)
 
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2006). Psoriasis and cytokine polymorphisms. In: Vandenbroeck, K. (Ed.). Cytokine Gene Polymorphisms in Multifactorial Conditions (321−335).. CRC Press Inc.
 
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2006). Interleukin-19 subfamily of cytokines. In: Vandenbroeck, K. (Ed.). Cytokine Gene Polymorphisms in Multifactorial Conditions (147−155).. CRC Press Inc.
 
Vasar, E.; Kõks, S.; Kingo, K.; Karelson, M.; Silm, H. (2003). Promoter polymorphism at position-592 of the interleukin-10 is not associated with early- and late-onset psoriasis. Journal of the European Academy of Dermatology and Venereology, 16, Supplement 1: 11th Congress of the European Academy of Dermatology and Venereology. 2-6 October 2002, Prague, Czech Republic. Bologna: Monduzzi Editore, 303−306.
 
Silm, H.; Karelson, M.; Kingo, K. (2001). Mentax 1% Cream in Treatment of Tinea Pedum and Tinea Inguinalis. Skin and Environment - Perception and Protection, 1-2: 10th Congress of the European Academy of Dermatology and Venereology; Munich, Germany; October 10-14, 2001. Ed. Ring, J.; Weidinger, S.; Darsow, U. Bologna: Monduzzi Editore, 281−284.
3.2. Artiklid/peatükid lisas mitte loetletud kirjastuste välja antud kogumikes
 
Kõks, S.; Kingo, K.; Vasar, E.; Silm, H. (2007). Interleukin-20. In: Zdanov, A. (Ed.). Class II Cytokines (145−160).. Research Signpost.
3.4. Artiklid/ettekanded, mis on avaldatud valdkonda 3.1. mittekuuluvates konverentsikogumikes
 
Karelson, M.; Kürsa, V.; Kingo, K.; Silm, H. (2003). Teleangiectasia macularis eruptiva perstans. 11th Congress of the European Academy of Dermatology and Venereology; Prague, Czech Republic; 2-6 October 2002. 93−95.
 
Kingo, K.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2002). Promoter polymorphism at position - 592 of the interleukin-10 is not associated with early and late-onset psoriasis. Proceedings 11th EADV Congress Prague 2002 “ More than Skin – deep” of the European Academy of Dermatology and Venerology, 16:1: Scientific Publishing&Communication. International Proceedings Division, 2003. 303−306.
3.5. Artiklid/ettekanded, mis on avaldatud kohalikes konverentsikogumikes
 
Silm, H.; Karelson, M.; Kaur, S.; Kingo, K. (1998). Lichen ruber Eestis. Arstiteaduskonna aastakonverents (72).. Tartu: TÜ Arstiteaduskond.
4.2. Teiste teadusväljaannete toimetamine, mis ei kuulu kategooriasse 4.1, aga mille väljaandnud kirjastus on akadeemiliselt piisavalt tuntud
 
Altmets, Mait; Altraja, Alan; Ambos, Anu; Andresen, Kadri; Arumäe, Katrin; Brachinsky, Mark; Elmet, Märt; Haldre, Sulev; Hedman, Anu; Kahu, Jaanus; Kaljusaar, Heli; Kallikorm, Riina; Karelson, Maire; Karjagin, Juri; Kaur, Sirje; Kingo, Külli; Koorits, Ursula; Kull, Karin; Kõrv, Janika; Linnamägi, Ülla ... Uuetoa, Tiina (2012). Eakate farmakoteraapia. Tallinn: Medicina.
5.1. Konverentsiteesid, mida kajastab Thomson Reuters Web of Science
 
Kurvits L, Taba P, Planken A, Kadastik-Eerme L, Reimann E, Kõks S, Kingo K (2018). Parkinson’s disease as a multisystem disorder: whole transcriptome study in Parkinson’s disease patients’ skin and blood – finding the pathomechanistic link. European Journal of Neurology, 25 (Suppl2), 126.
 
Lattekivi, F.; Reimann, E.; Keermann, M.; Abram, K.; Koks, S.; Kingo, K.; Fazeli, A. (2017). Multicomponent biomarkers: a novel method for accurate diagnosis of psoriasis. British Journal of Dermatology, 177 (5), E294−E295.
 
Planken, Anu; Kadastik-Eerme, Liis; Kurvits, Lille; Rinken, Siim; Pilv, Jaagup; Reimann, Ene; Kingo, Külli; Kõks, Sulev; Taba, Pille. (2013). Gene expression in skin of Parkinson's disease patients. Movement Disorders, 28 (S1): The MDS 17th International Congress of Parkinson's Disease and Movement Disorders, 16.-20.06.2013, Sydney, Australia. Wiley-Blackwell, S376−S377.
 
Plass, Dietrich; Mangen, Marie-Josée; Havelaar, Arie H; Gibbons, Cheryl; Haagsma, Juanita; Jahn, Beate; Lai, Taavi; van Lier, Alies; Longhi, Silvia; McDonald, Scott A; Kraemer, Alexander; Kramarz, Piotr; Cassini, Alessandro; Kretzschmar, Mirjam E. (2013). The incidence-based and pathogen-based disability-adjusted life-years approach for measuring infectious disease burden in Europe: the Burden of Communicable Diseases in Europe (BCoDE) project. The Lancet, 381, S114. DOI: 10.1016/S0140-6736(13)61368-9.
 
Soomets, U.; Kingo, K.; Mahlapuu, R.; Koks, S. (2011). Antioxidants have possible therapeutic activity for psoriasis. 6th International Congress of Psoriasis - from Gene to Clinic. E28−E28.
5.2. Konverentsiteesid, mis ei kuulu valdkonda 5.1
 
Shunina, Marina; Shahmatova, Liisi; Uibo, Raivo; Kingo, Külli; Kisand, Kai (2016). B cell subpopulations in psoriasis and vitiligo: differences in CD5 and HLA-DR expression. In: .Keystone Symposia - B Cells at the Intersection of Innate and Adaptive Immunity, May 29—June 2, 2016, Stockholm, Sweden.
 
Kärner, J.; Wawrzyniak, M.; Tankov, S.; Runnel, T.; Aints, A.; Kisand, K.; Altraja, A.; Kingo, K.; Akdis, C.; Akdis, M.; Rebane, A. (2016). Increased microRNA-323-3p in IL-22/IL-17-producing T cells and asthma: a role in regulation of the TGF-β pathway and IL-22 production. Eesti Arst, 95(Lisa 2), 37.
 
Šunina, Marina; Šahmatova, Liisi; Kisand, Kai; Uibo, Raivo; Kingo, Külli (2015). The alteration of HLA-DR expression on B cells from vitiligo patients. In: .Be There Or Die? The Role Of The Microenvironment In B Cell Behaviour In Health And Disease; Sant Feliu de Guixols, Spain, 16-21 May 2015.
 
Karelson, M.; Silm, H.; Kingo, K. (2012). Vitiliigohaigete elukvaliteedi ja emotsionaalse seisundi võrdlus psoriaasihaigete ning tervete vabatahtlikega. Eesti Arst: TÜ arstiteaduskonna aastapäeva teaduskonverents, Tartu, oktoober 2012. 23−23.
 
Karelson, Maire; Silm, Helgi; Salum, Tiit; Kõks, Sulev; Kingo, Külli (2011). Differences between familial and sporadic cases of vitiligo. Eesti Arst: Arstiteaduskonna päevad, Tartu, 13-14.okt.2011. 22−22. (90, lisa1).
 
Reimann, E.; Reemann, P.; Lilleoja, R.; Jaakma, Ü.; Kingo, K.; Vasar, E.; Silm, H.; Kõks, S. (2010). Whole transcriptome RNA-Seq of human dermal fibroblasts using SOLiD system. CRG Symposium: "Medical Genome Sequencing: Understanding the Genomes of Disease", Barcelona, Spain, 28.-29.10.2010.
 
Kingo, K.; Karelson, M.; Reimann, E.; Rätsep, R.; Vasar, E.; Silm, H.; Kõks, S. (2009). Association analysis of genes of IL19 cluster and their receptors in vitiligo patients. 18th Congress of the European Academy of Dermatology and Venereology (EADV); Berlin, Germany; 7-11 Oct 2009.
 
Oit, I., Mahlapuu, R., Raud, K., Kingo, K., Soomets, U. (2009). Effects of novel glutathione analogues on the expression of antioxidative enzymes. Abstract Book and Program: 5th Conference on Separation and Related Techniques by Nordic Separation Sciemce Society; Tallinn, Estonia; 26-29.08.2009. Ed. Borissova, M., Vaher, M. Infotrükk OÜ, 122.
 
Karelson, M.; Kingo, K.; Silm, H. (2008). Vitiliigo kliinilised vormid ja nende avaldumine. Eesti Arst, 87: TÜ Arstiteaduskonna päevad; Tartu; 9-10.okt 2008. OÜ Celsius Healthcare, 668−668. (9).
 
Oit, I.; Mahlapuu, R.; Raud, K.; Kingo, K.; Soomets, U. (2008). Glutatiooni analoogide mõju psoriaasihaigete mõningate antioksüdantsete ensüümide ekspressioonile. Eesti Arst 87(9): TÜ Arstiteaduskonna päevad; Tartu; 9. oktoober 2008. 670.
 
Karelson, M.; Kingo, K.; Kõks, S.; Vasar, E.; Salum, T.; Silm, H. (2007). Autoimmuunhaiguste kaasnemine ja autoantikehade esinemine vitiliigo haigetel. Eesti Arst, 86, 691.
 
Kingo, K. (2007). Regulation of the Glutathione System in Psoriasis. Abstract Book: BADV 7th Congress, Sept. 6-8, 2007. 64.
 
Kingo, K.; Raud, K.; Rätsep, R.; Kõks, S.; Silm, H.; Vasar, E. (2007). The gene expression of Interleukin-22 in plaque psoriasis. Abstract Book: 21 World Congress of Dermatology; Buenos Aires, Argentina; 01-05.oct. 2007. 203.
 
Pärna, E.; Abram, K.; Kingo, K.; Oona, M.; Silm, H. (2007). Psoriaasihaigete emotsionaalne enesetunne sõltuvalt haiguse raskusest. Eesti Arst, 689−690.
 
Karelson, M.; Kingo, K.; Kõks, S.; Silm, H.; Vasar, E.; Salum, T. (2007). Coexistence of vitiligo and autoimmune disorders in Estonia. Abstract Book: 21 World Congress of Dermatology, Buenos Aires, Argentina, 01-05.oct,2007. 344.
 
Pärna, E.P.; Abram, K.; Kingo, K.; Oona, M.; Silm, H. (2007). Emotional status in psoriasis patients in relation to the sevsrity of disorder. 12th Congress of the European Society for Dermatology and Psychiatry, Wroclaw, Poland, June 14th-17th, 2007. 46.
 
Kingo, K.; Karelson, M.; Aunin, E., Kõks, S.; Vasar, E.; Silm, H. (2006). Expression of Genes of Melanocortin system in Vitiligo. Dermatovenerologie, 51 (3): National Congress of Dermatology with Intyernational Participation. The XIIth ALP-Danube-Adria STD conference; 1- 4 november, 2006. Rumeenia, 2. (Suppl. 1).
 
Kingo, K.; Karelson, M.; Aunin, E.; Silm, H.; Vasar, E.; Kõks, S. (2006). Regulation of the cutaneous corticotropin releasing hormone - proopiomelanocortin systemin vitiligo. BADV 6th Congress; Latvia, Riga; 14 - 16 September, 2006. Ed. Rubins, A. Läti, Riia: Latvia, 41.
 
Raud, K.; Kingo, K.; Ehrlich, K.; Kõks, S.; Silm, H.; Vasar, E.; Soomets, U. (2006). Glutatsioonisüsteemi regulatsioon psoriaasi korral. Eesti Arst, 85 (9): Arstiteaduskonna päevad 2006. 633−634.
 
Philips, M.-A.; Kingo, K.; Kõks, S.; Aunin, E.; Karelson, M.; Silm, H.; Vasar, E. (2006). Myg1 protein is functionally important in both brain and skin. FENS Forum Abstracts, 3: 5th Forum of European Neuroscience; Vienna, Austria; 08 - 12 July, 2006.
 
Kingo, K.; Aunin, E.; Karelson, M.; Rätsep, R.; Philips, M.A.; Luuk, H.; Kõks, S.; Silm, H.; Vasar, E. (2006). Melanokortiini - süsteem ja vitiliigo. Eesti Arst, 85 (9): TÜ arstiteaduskonna teaduskonverents; Tartu; 13.10.2006. , 647.
 
Rätsep, R.; Karelson, M.; Kingo, K.; Aunin, E.; Kõks, S.; Silm, H.; Vasar, E. (2006). Interleukiinide ja nende retseptorite ekspressioon vitiliigoga patsientide ja kontrollgrupi nahas. Eesti Arst, 85(9): TÜ arstiteaduskonna teaduskonverents; Tartu; 13. oktoober 2006. 618.
 
Kingo, K.; Rätsep, R.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Genetic influence on IL-10 expression of patients with plaque type psoriasis. JEADV : Journal of the European Academy of Dermatology and Venereology, 18 (Suppl. 2), 337.
 
Kingo, K.; Rätsep, R.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Association between interleukin-19 and interleukin-20 genetic polymorphisms and plaque-type psoriasis. 16th Congress of Latvian Association of Dermatovenerologists, "Latest Achievements in Skin and Sexually Transmitted Diseases Diagnostics and Therapy"; Riga, Latvia; September 10-11, 2004.
 
Rätsep, R.; Kingo, K.; Kõks, S.; Karelson, M.; Silm, H.; Vasar, E. (2004). Interleukiin-19 ja interleukiin-20 geenide haplotüüpide efektid psoriaasi avaldumisele. 625.
 
Kingo, K.; Kõks, S.; Silm, H.; Vasar, E. (2003). Polymorphism in the promoter region of the interleukin-20 gene - relationship to psoriasis vulgaris. JEADV : Journal of the European Academy of Dermatology and Venereology, 17, Suppl. 3, 378.
 
Kingo, Külli; Kõks, Sulev; Silm, Helgi; Vasar, Eero (2003). Interleukiin-20 geneetiliste polümorfismide seos psoriaasiga. Eesti Arst, 9, 631.
 
Silm, H.; Kingo, K.; Paasik, K.; Kink, R. (2002). The efficiency of copper vapour laser equipment for treatment of patients with rosacea. Annales de Dermatologie et de Venereologie, 129, 1S615.
 
Karelson, M.; Kürsa, V.; Kingo, K.; Silm, H. (2002). Teleangiectasia macularis eruptiva perstans. Journal of the European Academy of Dermatology and Venereology, 16, Suppl. 1: 11th Congress of the European Academy of Dermatology and Venereology. Brussels, 198.
 
Silm, H.; Kingo, K.; Väli, M.; Karelson, M. (2001). Alopecia areata in assocation with thyroid diseases. Pediatric Dermatology, 18 (4): Annual Meeting of the Society for Pediatric Dermatology. 98.
 
Silm, H.; Karelson, M.; Kingo, K. (2000). The factors promoting the developing of lichen planus in Estonia. Baltic association of dermatovenereology 3rd congress; Riga, Latvia; September 7-9, 2000. 90.
 
Kingo, K.; Abram, K.; Silm, H. (2000). Pemphigus herpetiformis - the new pemphigus variant. Journal of the European Academy of Dermatology and Venereology, 14, Suppl. 1: 9th Congress of the European Academy of Dermatology and Venereology; 11-15 October 2000; Geneva, Switzerland. , 195.
 
Silm, H.; Kaur, S.; Karelson, M.; Kingo, K. (1998). The factors that promote developing lichen ruber planus in Estonia. Journal of the European Academy of Dermatology and Venereology, 11, Suppl. 2: 7th Congress European Academy of Dermatology and Venereology; France, Nice; 7-11 October 1998. Nice: Elsevier Science BV, S253.
 
Reimann, E.; Kingo, K.; Karelson, M.; Silm, H.; Aunin, E.; Raud, K.; Vasar, E.; Kõks, S. (0). Gene expression study of CRH-POMC system including endogenous opioids in vitiligo skin biopsies and peripheral blood mononuclear cells. Perspectives in Neuroimmunology; Tartu; October 26-28, 2009.
6.2. Õpikud ja muud õppeotstarbelised publikatsioonid, v.a. kõrgkooliõpikud;
 
Kaur, Sirje; Silm, Helgi; Kingo, Külli; Karelson, Maire; Abram, Kristi. (2010). Nahahaigused. Eesti, Tartu ülikooli kirjastus: University of Tartu.
6.3. Populaarteaduslikud artiklid;
 
Kingo, K. (2006). Naastuline psoriaas. Lege Artis, 44−45.
 
Raudsepp, H.; Kukk, T.; Kingo, K.; Pärna, E.; Rajangu, H.; Tampere, M.; Tampere, T.; Topnik, A.; Rannala-Lille, T.; Konno, P.; Dejeva, E.; Tedremets, L.; Kivimägi, K.; Allik, M.t; Kesküla, E.; Pohlak, T.; Järna, S.; Mets, H.-R.; Kirsimägi, Ü. (2006). Akne ravi Rouccutanega suvekuudel. Lege Artis, 28−30.
6.6. Muudes ajakirjades ja ajalehtedes avaldatud artiklid;
 
Kingo, K. (2004). Psoriaas ja geenid. Moodne Meditsiin, 18−19.
 
Silm, H.; Kingo, K. (2003). Esimesed kogemused psoriaasi ravimisel Daivobet salviga. Hippokrates, 45, 431−434.
6.7. Muu loome
 
Silm, Helgi; Kõks, Sulev; Kingo, Külli; Rätsepp, Ranno; Kaur, Sirje; Abram, Kristi; Pärna, Ene; Kingo, Külli; Karelson, Maire (2008). Kliinik 2008 : psoriaasi patogenees ja ravi - kaasaegsed arengusuunad TÜ Nahahaiguste Kliinikus [Videosalvestis]. Kliinik 2008, Tartu Ülikooli Kliinikumi täienduskonverents; Tartu; 4. - 6. veebruar, 2008. Tartu: TÜ IT Multimeedia talitus,. (TÜ filmiarhiiv).
6.8. Lühikirjutised teadusajakirjades ja kogumikes
 
Traks, T; Keermann, M; Karelson, M; Rätsep, R; Reimann, E; Silm, H; Vasar, E; Kõks, S; Kingo, K (2019). Polymorphisms in melanocortin system and MYG1 genes are associated with vitiligo. Journal of the European Academy of Dermatology and Venereology, 33 (2), e65−e67. DOI: 10.1111/jdv.15195.
 
Reemann, Paula; Reimann, Ene; Ilmjärv, Sten; Porosaar, Orm; Silm, Helgi; Jaks, Viljar; Vasar, Eero; Kingo, Külli; Kõks, Sulev (2017). Correction: Melanocytes in the Skin - Comparative Whole Transcriptome Analysis of Main Skin Cell Types. PLoS ONE, 12 (3), e0173792−e0173792. DOI: 10.1371/journal.pone.0173792.
13.04.2021